care institute of medical sciences outcomes
TRANSCRIPT
Outcomes2019
Care Institute of Medical Sciences
A premier multi-super specialty hospitalGREEN
Green Hospital JCI (USA)Certificate No. MC-3049
01
What's Inside
n
n Board of Directors 05
n Awards 06
n Abbreviations 07
n About CIMS 11
n Departmental Overview 15
n Liver Transplant 17
n In Vitro Fertilization Center 18
n Heart Transplant 20
n Bone Marrow Transplantation Unit 22
n Renal Transplant Center 24
n Blood Bank 26
n Genetic Center 28
n Fever Clinic 30
n Cardiology 31
n Cardiac Investigations 39
n Cardiac Rhythm Disorders 41
n Cardiac Surgeries 43
n Heart Failure 46
n Cardiac Valve Disorders 47
n Minimal Invasive Cardiac Surgery 48
n Paediatric Cardiac Sciences 49
n Vascular and Endovascular Surgery 50
n Thoracic 52
n Orthopaedic 54
n Pulmonary Medicine 57
n Neuro and Spine Surgery 58
n Trauma Center 60
n Gastro-Intestinal and General Surgery 62
n Endoscopy 63
n Oncology 65
Vision, Mission and Values 04 n
n Urosurgery 68
n Plastic Surgery 69
n Obstetrics and Gynaecology 70
n Neonatal Center 71
n ENT 72
n Pain Management 73
n Dentistry 74
n Pathology 75
n Radiology 79
n Physiotherapy, Rehabilitation and Nutrition 80
n Code Blue 81
n Quality Measures 82
n Ambulance and Transport Services 83
n Care at Homes 84
n Patient's Say 86
n Ethics 87
n Research Projects 88
n CIMS Foundation 94
n CIMS Learning Center 95
n CIMS Education 96
n Publication List 97
Nephrology 67
02
03
To be one of the most trusted
hospital in India by providing personalized care
for best patient experience.
VISION
Care
Innovation
Manage Lives
Save Lives
MISSION
To provide superior quality
Health Care using Innovation
to Manage and Save lives.}VALUES
Patient’s well-being: It will be our top most priority
To Serve with a Smile
Adopt and encourage ethical practices
Provide a safe and comfortable working environment
to employees and associates
Embrace technology and innovation in the delivery
of healthcare
Provide socially responsible and safe healthcare
Comply with all applicable laws and regulations
04
Vision, Mission and Values
05
Board of Directors
Dr. Hemang Baxi
Director
Dr. Anish Chandarana
Executive Director
Dr. Milan Chag
Managing Director
Dr. Urmil Shah
Director
Dr. Ashit Jain
Director, USA
Dr. Dhiren Shah
Director
Dr.(Prof.) Dilip Mavlankar
Director, India
Dr. Satya Gupta
Director
Dr. Kamlesh Pandya
Director, USA
Dr. Ajay Naik
Director
Mr. Kirti Patel
Director, UK
Dr. Keyur Parikh
Chairman
06
Awards
Best Multispeciality Hospital
of the Year 2019, GujaratCSR Health Impact Awards 2019
rd3 Digital Health Innovation
Summit 2019
Gujarat Healthcare Leadership Awards 2019 Joint Commission International - 2019
07
Abbreviations
2D 2 Dimensional
3D 3 Dimensional
4D 4 Dimensional
ACCF American College of Cardiology Foundation
ACEI Angiotensin -Converting -Enzyme Inhibitor
ACLS Advanced Cardiac Life Support
ACR American College of Radiology
ACS Acute Coronary Syndrome
AHA American Heart Association
AIDS Acquired Immune Deficiency Syndrome
AMA American Medical Association
ARB Angiotensin II Receptor Blocker
ASD Atrial Septal Defect
AV Aortic Valve
AVM Arteriovenous Malformation
AVR Aortic Valve Replacement
BA/BE Bio Availability/ Bio Equivalent
BAS Balloon Artrial Septostomy
BAV Balloon Aortic Valvuloplasty
BLS Basic Life Support
BMI Body Mass Index
BMT Bone Marrow Transplant
BSI Blood Stream Infection
CABG Coronary Artery Bypass Grafting
CAD Coronary Artery Disease
CAE Carotid Artery Endarterectomy
CAS Carotid Artery Stenting
CBC Complete Blood Count
CCU Critical Care Unit
CHD Coronary Heart Disease
CIED Cardiovascular Implantable Electronic Devices
CLC CIMS Learning Center
COPD Chronic Obstractive Pulmonary Disease
CPR Cardiac Pulmonary Resuscitation
CRRT Continuous Renal Replacement Therapy
CRT Conformal Radiotherapy
CRT-D Conformal Radiotherapy- Dimensional
CT Computed Tomography
CT-SCAN Computed Tomography
CV Cardiovascular
CVD Cardiovascular Disease
D2B Door to Balloon
DAP Dose Area Product
08
Abbreviations
DBP Diastolic Blood Pressure
DHS Dynamic Hip Screw
DLCO Diffusing Capacity of the Lungs for Carbon
Monoxide
DVR Double Valve Replacement
ECG Electrocardiogram
ECHO Echocardiography
ECMO Extracorporeal Membrane Oxygenation
ENT Ear, Nose, Throat
EP Electrophysiology
EPS Electrophysiology Study
ERCP Endoscopic Retrograde Cholangio
Pancreatography
FDA Food and Drug Administration
FESS Functional Endoscopic Sinus Surgery
FISH Fluorescence In Situ Hybridization
FT Flurotime
GERD Gastroesophageal Reflux Disease
GI Gastrointestinal
GICU General Intensive Care Unit
GIST Gastrointestinal Stromal Tumor
H2F Hospital to Family
H2H Hospital to Home
HAI Hospital Acquired Infection
HDL High Density Lipoprotein
HDU High Dependency Unit
HEPA High Frequency Particulate Air
HFOV High Frequency Oscillatory Ventilation
HIV Human Immunodeficiency Virus
HLA Human Leukocytic Antigen
HPV Human Papilloma Virus
ICCU Intensive Coronary Care Unit
ICD Implantable Cardioverter Defibrillator
ICH-GCP International Council of Harmonisation -
Good Clinical Practice
ICMR Indian Council of Medical Research
ICSI Intra Cytoplasmic Sperm Injection
ICU Intensive Care Unit
IITV Image Intensifier Television
IMRT Intensity Modulated Radiotherapy
IUI Intrauterine Insemination
IV Intravenous
09
Abbreviations
IVF In Vitro Fertilization
IVU Intravenous Pyelogram
JIC Joint International Conference
LDL Low Density Lipoprotein
LOS Length of Stay
LV Left Ventricular
LVEF Left Ventricular Ejection Fraction
LVRS Lung Volume Reduction Surgery
MDR Multi-Drug-Resistant
MICAS Minimally Invasive Cardiac Surgery
MLC Multileaf Collimator
MRA Magnetic Resonance Angiography
MRI Magnetic Resonance Imaging
MUFA Monounsaturated Fatty Acids
MV Repair Mitral Valve Repair
MVR Mitral Valve Replacement
NABH National Accreditation Board for Hospital &
Healthcare Providers
NABL National Accreditation Board for Testing and
Calibration Laboratories
NBP Noninvasive Blood Pressure
NCDR National Cardiovascular Drug Registry
NIBP Non-Invasive Blood Pressure
NICU Neonatal Intensive Care Unit
NIEPS Non Invasive EP Study
NO Nitric Oxide
OPD Out Patients Departments
OT Operation Theatre
PAD Peripheral Arterial Disease
PAMI Primary Angioplasty in Acute Myocardial
Infarction
PCI Percutaneous Coronary Intervention
PCNL Percutaneous Nephrolithotomy Surgery
PDA Patent Ductus Arteriosus
PERM Programme Electronic Review Management
PFO Patent Foramen Ovale
PFT Pulmonary Function Test
PGD Preimplantation Genetic Diagnosis
PM10 Particulate Matter 10
PM2.5 Particulate Matter 2.5
PPPPP Prior Planning Prevents Poor Performance
PRP Platelet-Rich Plasma
10
Abbreviations
PT Prothrombin Time
PT CA Percutaneous Transluminal Coronary
Angioplasty
PTSMA Percutaneous Transluminal Septal Myocardial
Ablation
PUFA Poly Unsaturated Fatty Acids
PVL Peri Ventricular Leukomalacia
QCI Quality Council of India
RCT Root Canal Treatment
RFA Radiofrequency ablation
RVG Radionuclide Ventriculogram
SBP Systolic Blood Pressure
SICU Surgical Intensive Care Unit
SLE Systemic Lupus Erythematosus
SO Sulfur Dioxide2
SPO Peripheral Capillary Oxygen Saturation2
SSI Surgical Site Infection
STEMI ST-Elevation Myocardial Infarction
SVR System Vascular Resistance
TAVI Transcatheter Aortic Valve Implantation
TB Tuberculosis
TEVAR Thoracic Endovascular Airtic Repair
TFA Trans Femoral Approach
TIFFA Targeted Imaging for Fetal Anomalies
TMT Tread Mill Test
TOF Tetralogy of Fallot
TOT Transobturator Tape
TPN Total Parental Nutrition
TRA Trans Radial Approach
TTI Transfusion Transmitted Infection
TURBT Trans Urethral Resection of Bladder Tumor
TURP Trans Urethral Resection of the Prostate
TV Tidal Volume
TVT Tension Free Vaginal Tape
URS Ureteroscopic
US United States
USG Ultra Sonography
UTI Urinary Track Infection
VAD Ventricular Assist Device
VAP Ventilator-Associated Pneumonia
VATS Video Assisted Thoracic Surgery
VIU Visual Internal Urethrotomy
VMAT Volumetric Modulated Arc Therapy
VSD Ventricular Septal Defect
VSG Vertical Sleeve Gastrectomy
WBC White Blood Cell
XDR Extensively Drug Resistant
11
About CIMS
Care Institute of Medical Sciences (CIMS) Hospital has a mission to serve its
patients compassionately and effectively for safe and quality healthcare.
Spread across two wings, East and West, CIMS is a 350-bed multispecialty
hospital providing a range of outpatient and inpatient, preventive, diagnostic
and treatment services. With a team of over 450 doctors and a staff of over
1000, we are committed to maintain the highest standards in delivery of
healthcare.
We are proud to be the recipients of all major international (JCI-USA) and
national quality accreditations (NABH, NABL, Green OT, Green Pharmacy)
ensuring the best treatment for all patients. With our established reputation of
clinical excellence and empathetic care, you can look forward to a
compassionate approach by our dedicated team of caregivers. Our 4C values
of Care, Compassion, Courtesy and Competency guide us at every step of
the treatment and journey of the patient within the hospital. Our aim is to be the
first satisfied choice for your healthcare.
CIMS Flagship
CIMS Hospital was awarded being the best hospital in Gujarat for 2019 by the
International Health Care Awards.
ŸCIMS Hospital has become the most acclaimed name in health care
industry across Gujarat, Rajasthan and Madhya Pradesh.
ŸWith consultant availability 24×7 and having the best teams for all
specialties, CIMS Hospital has produced some amazing life saving results.
12
About CIMS
ŸThe First Exclusive Trauma Center in Western India to have protocol based
management of Trauma (ATLS protocols) headed by a qualified trauma
surgeon
ŸComprehensive Renal Transplant Program with stringent processes in
place following international guidelines and practices.
Dedicated to delivering best patient care, the hospital hosts cutting edge
technology and is committed to innovation in providing treatment
across all spectrums manifested in being a pioneer as follows:
ŸJCI (Joint Commission International ), NABH(National Accreditation Board
for Hospitals and Healthcare Providers) and NABL(National Accreditation
Board for Testing and Calibration Laboratories) accreditation
ŸNABH ER, NABH Ethics committee (First in India), Green OT, Green
Pharmacy
ŸFirst Heart Transplant Surgery of Gujarat
ŸPaediatric Bone Marrow Transplant Unit – First in Gujarat
ŸRadial Lounge (One of the first in the country)
ŸTAVI (Transcatheter Aortic Valve Implantation ) – First in Gujarat
ŸDigitised OTs and ICUs for better patient care – First in Gujarat
ŸCertified Heart and Renal Transplant Centre
ŸFirst ever ECMO (Extracorporeal Membrane Oxygenation) machine for
patients with cardio respiratory failure
ŸFirst in Asia Pacific to set up Elekta Versa HD for cancer radiation treatment
ŸOne of the only private Hospital in Western India with 3 cath labs
International Centers Of Excellence Certificate No. MC-3049
13
About CIMS
ŸOne of the only Indian International Centre of Excellence(ICOE) certified by
American college of Cardiology (ACC)
ŸCare at Homes : A branch of homecare for medical and nursing care at
home
ŸHospital to Home visits to improve drug (medicine) adherence and patient
compliance
ŸA fleet of well equipped ambulances
ŸOne of the highest nurse patient ratio across the industry
ŸExclusive Trauma Center following ATLS (Advanced Trauma Life Support)
protocols
ŸRound-the-clock dialysis facility
ŸEthics Committee that provides assistance with ethical issues related to
patients’ safety and well being.
14
About CIMS
TECHNOLOGICAL EXCELLENCE
State-of-the-Art Equipment
Ÿ 3 High-end Cath Labs with DSA and stent boost facility
Ÿ CT Scan Revolution EVO 128 slice-First in India
Ÿ MRI Signa Explorer-First in India
Ÿ Electrophysiology with 3D system
Ÿ Echocardiography machines with 3D-TEE, 3D adult and pediatric Echo
Ÿ 24 x 7 x 365 'Stroke' unit with latest CT scan with CT angiography
and perfusion scan facilities
Ÿ PACS system to view various imaging in ICU and doctor's lounge
Ÿ Fully digitised ICUs and OTs
Ÿ Carto-3 system, state-of-the-art imaging system offers enhanced
visualization for treating arrhythmia patients
Ÿ State-of-the-art 12 operation theaters; 4 modular OT's with class 100
laminar air flow traction device with IITV to support all types of trauma
Ÿ Extracorporeal membrane oxygenation (ECMO)
Ÿ Dedicated Neutropenic Care
Ÿ Gujarat’s First Carl Zeiss Pentero 900 Microscope (High - end path breaking
innovation for enhanced visualization during surgery)
Ÿ First in Gujarat Pentax Medical EBUS Ultrasound for crystal clear
ultrasound imaging, high patient tolerance, enlarged working channel for
the staging of lung diseases and to support diagnostic accuracy.
15
Department Overview :
V
Department
16
Department Overview :
Gynaecology
Orthopaedic
1986 2477
(NON-CARDIAC)
17
Liver Transplant
Liver transplant gives patients with end-stage liver disease a
second chance for life. CIMS liver transplant unit provide
state of the art facility and advance technology to make
transplantation safer and more successful.
We perform transplants using both deceased and living
donors, and are able to perform complex transplants on
patients with complicating health conditions, such as portal
vein thrombosis.
Our skilled transplant team includes
ŸLiver Transplant Surgeons
ŸHepatologists
ŸNurses
ŸPhysician Assistants
ŸPharmacists
ŸDieticians
ŸPhysiotherapist
ŸTransplant Co-ordinator
ŸSocial Worker
Liver transplant pathologists and interventional radiologists
also help accurately diagnose and manage liver disease
and liver cancer progression before transplant. Nurses and
other providers who specialize in caring for liver transplant
patients staff our dedicated transplant unit.
CIMS has completed three liver transplants with 100%
successful rate
Key Features
ŸAccess valuable pearls, pitfalls, and insights from best
surgeon, of the world's preeminent experts in liver surgery.
ŸUnderstand today's full range of transplantation
techniques with complete step-by-step descriptions of
each, and access the background information and
management options for each hepatic disease entity.
ŸTake advantage of detailed discussions of everything
from pathophysiology and patient and donor selection, to
transplantation anaesthesia and operative procedures;
immunosuppression; postoperative care; and ethical
issues.
In addition to treating liver failure, we specialize in treating all
diseases of the liver and bile ducts. Areas of expertise
include primary and metastatic tumors of the liver, bile duct
problems, portal hypertension, liver cysts and all types of
hepatitis. Our liver transplant provides state-of-the-art care
for these difficult problems.
Our goal is to restore quality of life to patients with
advanced liver disease.
18
In Vitro Fertilization Center
In Vitro Fertilization Center
The unit team offers unparalleled experience in all areas of
reproductive medicine including the most advanced and
effective treatments for infertility. As a part of the CIMS
obstetries and gynaecology center, we bring to patients the
superior resources and capabilities of one of the best
hospital in the country.
CIMS In Vitro Fertilization(IVF) dedicated team
includes:
• Physicians
• Nurses
• Embryologist
• Ultrasound Technicians
• Psychologist
These staff members are among the most experienced and
accomplished medical professionals in their fields, including
specialist in reproductive endocrinology, reproductive
urology, embryology, andrology, immunology, gynaecology,
genetics and related areas.
The various treatments include:
In Vitro Fertilization (IVF): A basic technique, in which
oocytes have been aspirated from the woman body, usually
after hormonal treatment, to undergo fertilization with the
husband's sperm in the laboratory. The new embryo is
transferred back to the women uterus in order to achieve
pregnancy.
1. Intra Cytoplasmic Sperm Injection (ICSI): A technique
in which an isolated sperm is chosen and injected directly
into the egg in order to achieve fertilization. This technique
19
In Vitro Fertilization Center
5. Pre-implantation Genetic Diagnosis (PGD): A new
technique enabling us to diagnose genetic disease in the
embryonal stage. Using biopsy of a single cell of the
developing embryo, combined with advanced molecular
biology techniques, we can identify embryos that carry the
gene for certain inherited diseases. This capability reduces
the risk that these diseases will be passed on to children.
This technique enables us also to diagnose male and female
embryo, when relevant in cases of sex-related diseases.
6. Male factor treatments: Our male reproductive unit
includes comprehensive services for the treatment of male
infertility, including surgical repair of varicoceles, electro
ejaculation and epididymis and testicular sperm retrieval for
use with IVF and ICSI.
made a revolution in the treatment of male infertility, and is
efficient for low sperm count, or difficulty in regular
fertilization.
2. Embryos Cryopreservation: A technique that is used
to preserve embryos which are not immediately
transplanted. This technique enables the embryos to be
saved for future implantation and pregnancy.
3. Oocyte Cryopreservation: A new technique which
enable us to freeze eggs to preserve fertility in cancer
patients before they undergo chemotherapy, or single
women who wish to defer motherhood.
4. Ovarian Tissue Freezing: Revolutionary procedures
that can help woman maintain the viability of ovarian
function, mainly in cases of cancer patients before
chemotherapy.
20
Heart Transplant
We provide the most innovative and sophisticated care from nationally-
recognized heart transplant surgeons.
ŸFirst in Gujarat to provide service of Heart Transplant
ŸPerformed 9 successful heart transplants till date
ŸSpecially established heart failure clinic for patient education and
awareness
ŸFacility to provide ventricular assist devices and biventricular pacemaker
therapy
ŸHospital to Home facility for the waiting time and post operative care In
addition to being a leader in heart transplant surgery, we are also dedicated
to improving transplant therapies that decrease the chances of heart failure.
ŸCIMS doctors' experienced and integrated team approach results in
transplant outcomes that compare favorably with national averages. Teams
work with transplant recipients before, during and after surgery to ensure the
greatest likelihood of superior results.
ŸCIMS Hospital is the best heart transplant hospital in Gujarat and we have
the highest volume for heart transplants in Gujarat with a 100% success rate
for the transplant.
21
Heart Transplant
CIMS HOSPITAL : GUJARAT’S FIRST HEART TRANSPLANT CENTRE
I am grateful to CIMS Doctors for giving me a new life completion of such a major operation
I got new life and ray of hope after getting heart transplant operation at CIMS Hospital. I am thankful to CIMS Doctors for new lease of life to me. I
appeal to all Indian Peoples to come forward and take part in Donating organs, so that we can save somebody’s life.
I am thankful to Heart transplant team of CIMS Hospital for giving me new life and normal life, I am indebted to Kushal Goswami family who gave
heart donation for my transplant surgery
22
Bone Marrow Transplant
CIMS Centre for Bone Marrow Transplant is one of the best in Gujarat and
India. Centre for Bone Marrow Transplant is a stand alone dedicated facility,
equipped with ultra-modern infrastructure and internationally trained, widely
experienced faculty. The Centre is supported by state-of-the-art laboratory
services and transfusion services, along with a fully equipped radiation
oncology unit with facility for total body irradiation. The Centre offers allogenic
transplant using bone marrow.The center performs Matched Related Donor
(MRD) as well as Haploidentical Transplant from parents.
CIMS Bone Marrow Transplant Unit has Performed 97 BMT with 95%
Disease free Survival Success Ratio.
Key Department Highlights
ŸEach room is supported by separate isolation unit
ŸTransplants are routinely performed for children
ŸLeading bone marrow transplant and high end Hematology reference center
ŸBoth Allogenic and Autologous stem cell bone marrow transplantations are
done for various Hematological disorders, Auto immune disorders and
Genetic disorders
ŸRehab and Counselling – This supportive service is very essential for the
Haematology Department and is taken care of by a team of expert
Physiotherapists, Yoga specialists and Clinical Psychologists
ŸOne of the Tertiary Haematology referral unit in India
ŸOngoing Leukemia, Hemophilia/Lymphoma, Myloma programme
Support services from Haematology Lab
• Routine investigations
• Coagulation studies
• Hemolytic work up
• Thrombophilic work up
• Immunophenotyping
• Molecular Genetics
• Cytogenetics and FISH Lab
• 24 hours Blood Bank
23
Bone Marrow Transplant
High Quality Care at affordable costs at Sankalp- CIMS
Center for Pediatric Bone marrow Transplantation .
Sankalp India Foundation jointly with support of CIMS
hospital takes care of the financial, socio-economic and
patient management aspects at the Center. Italy based
Cure2Children Organization under leadership of
Dr. Lawrence Faulkner joined hands to provide expert
protocol based care to such patients.This joint venture
is a conglomeration of three organizations, which are
committed to this noble cause and believe that no child with
thalassemia, if eligible for transplants should be denied ,
either due to lack of funds or facilities.
The Sankalp India foundation supports patients, their
families or caregivers at every step during the transplant.
No transplant patient should ever feel alone.
A bone marrow, stem cell or cord blood transplant is an
overwhelming experience—physically , emotionally ,
logistically and financially—both for patients and for their
families.
The Sankalp India foundation joined hands with CIMS in
2016 with a single vital goal: to improve the quality of
life for children who are undergoing transplantation as a
life saving treatment for thalassemia and sickel cell
anemia.
The Bone Marrow Foundation is guided by a medical
advisory board of nationally recognized physicians in the
field of transplantation. Our Bone Marrow Transplantation
unit provides vital financial assistance for donor
searches, compatibility testing, bone marrow or stem cell
collection, cord blood banking, medications, medical
equipment, home and child care services, housing,
transportation and other patient needs.
20
38 39
0
5
10
15
20
25
30
35
40
45
2017 2018 2019
Bone Marrow Transplantation
ŸExclusively focussed on thalassemia and blood
disorder patients
ŸBest care adhering to expert protocols
ŸA 4-bed dedicated unit for Paediatric Bone Marrow
Transplant with exclusive focus on thalassemia
haemoglobinopathies
ŸAll inclusive holistic approach towards thalassemia
starting from pre to post transplant care
ŸA nonprofit initiative by CIMS Hospital, Ahmedabad,
Sankalp India Foundation and Cure2Children
Organization, Italy
24
Renal Transplant Center
CIMS’s Kidney Transplant Program has saved and
improved lives.
Every patient benefits from state-of-the-art medical
expertise, the finest renal surgeons and equipment, and
focus first and foremost on well-being.
Each patient receives unique access to all medical
treatments in one location and benefits from an important
personal touch: the entire team – including a patient
coordinator for each transplant patient – is dedicated to
ensure an optimum experience for the patient and family .
With the blue print in place, CIMS poises for a
comprehensive RENAL TRANSPLANT program with
stringent processes in place following international
guidelines and practices, maintaining its registry.
CIMS Renal Transplant Team has successfully
completed 10 Renal Transplants so far.
State-of-the-art procedures for kidney transplantation
include:
A. Living donor kidney transplants
B. Cadaveric renal transplantation
Renal Transplant Team
1. Renal transplant programme coordinator for counseling
sessions for patient and relatives
2. Renal Transplant Committee constituted by subject
matter experts and key opinion leaders for transparent, non-
objectionable ethical review
3. Best infection control practices while harvesting kidney to
be transplanted and also throughout the procedure.
25
Renal Transplant Center
Renal Transplant Salient features:
ŸThe center functions under the able hands of
experienced and efficient urologists and transplant
surgeons so as to perform minimally invasive surgery,
with minimum post-operative recovery time and
hospitalization.
ŸThe already existing state-of–the art-operation theaters
offer a sterile, post-operative environment, controlling
infections and continuous patient monitoring.
ŸIn house diagnostic services-pathology and radiology will
make the procedure ABO and Human Leukocytic Antigen
(HLA) compatible and compliant.
ŸThe kidneys are well transplanted such that cold and warm
ischemia times are as short as possible.
ŸThe ethical/legal committee reviews and permissions are
finally implemented.
ŸThe operating protocol are certified ethically and legally
26
Blood Bank
Only a life lived for others is a life worth while .In India, Heath
System currently operates within an environment of rapid
social, economical and technical changes. Such changes
raises the concern for the quality of health care. Blood banks/
blood centers are an integral part of health care system.
Accreditation would be the single most important approach
for improving the quality of blood banks.
Blood transfusions are a critical part of everyday life and
assist in saving countless lives each year.
Blood bank requires a vast array of state of the art
equipment for its smooth functioning , Listed below :
ŸDeep Freezers which maintain temperatures of -30° C and
-80° C
ŸHeavy duty refrigerated centrifuge for the separation of
components at different speeds
ŸPlatelet agitators
ŸCryobath
ŸTube Sealers
ŸBlood Collection Monitors
All the above equipment have automatic temperature
monitors and digital readout systems as well as automatic
alarms, with continuous temperature surveillance, which
ensure the safety of the blood and components issued from
the Blood Bank.
CIMS Blood Bank ensures safety of blood donor and blood
recipient (patient)
“Safe Blood” gives life, “Unsafe blood” gives infections.
27
Blood Bank
Standard Operation Process for Blood Transfusion
Ÿ “Strict Donor Screening”
Ÿ “Testing” of collected blood as per WHO & NACO specified
standards
ŸReliable “cross-matching” of blood samples to ensure safe
blood transfusion to patient
We follow international protocols of donor eligibility criteria to
ensure safety of blood donor.
28
Genetic Center
CIMS Clinical Genetic team works into the causes and
inheritance of genetic disorders.
We treat birth defects and dysmorphology, mental
retardation, autism, and mitochondrial disorders, skeletal
dysplasia, connective tissue disorders, cancer genetics,
teratogens and prenatal diagnosis.
We treat or advice regarding neurologic, endocrine,
cardiovascular, pulmonary, ophthalmologic, renal,
psychiatric and dermatologic conditions.
Our clinical geneticist’s advice with particular attention to
hereditary disorders.
Examples of genetic syndromes that are commonly
seen in patients include :
• Chromosomal rearrangements
• Down’s syndrome
• DiGeorge syndrome (22q11.2 Deletion Syndrome)
• Fragile X syndrome
• Marfan syndrome
• Neurofibromatosis
• Turner syndrome
• Williams's syndrome
29
Genetic Center
Services Offered at CIMS Genetics Centre
ŸDiagnostic evaluation.
ŸManagement of inborn errors of metabolism, skeletal
dysplasia, or lysosomal storage diseases.
ŸA prenatal genetics clinic to discuss risks of pregnancy
(advanced maternal age, teratogen exposure, family
history of a genetic disease), test results (abnormal
maternal serum screen, abnormal ultrasound), and/or
options for prenatal diagnosis (typically amniocentesis or
chorionic villus sampling).
ŸSupport of a clinical geneticist or genetic counselor for
cancer genetics, cardiovascular genetics, craniofacial or
cleft lip/palate, hearing loss clinics, muscular dystrophy /
neuro degenerative disorders.
ŸGenetic counseling: the process of providing information
about genetic conditions, diagnostic testing, and risks in
other family members, within the framework of
nondirective counselling.
ŸOur genetic counsellors guide in family risk assessment
and counselling of patients regarding genetic disorders.
The geneticist's advice is helpful in cases of
Ÿ Advanced maternal age (age 35 or older)
ŸFirst trimester/nuchal screening pre-test education/
counselling
Ÿ Abnormal maternal serum screening
ŸConcerns about genetic disease because of ethnicity –
Thalassemia, Sickle Cell Disease
Ÿ Abnormal ultrasound findings
ŸPrevious child with a genetic condition, birth defect(s)
and/or mental retardation
ŸRecurrent miscarriages
ŸFamily/personal history of genetic condition
ŸFamily/personal history of birth defect(s)
ŸFamily/personal history of mental retardation
ŸMedication exposures during pregnancy
ŸConsidering Preimplantation Genetic Diagnosis (PGD)
30
Fever Clinic
The High Level Isolation Unit (HLIU) is run by a dedicated team of doctors,
nurses and laboratory staff from the CIMS infectious diseases service. Access
to the unit is restricted to the team of specially trained medical staff. The HLIU
is designed to ensure our medical staff can safely treat a patient with a
dangerous infectious disease. A specially-designed tent with
controlled ventilation is set up around the patient’s bed and allow the staff to
provide clinical care handling the infection.
ŸThere are various facilities in place including a specific entrance for the
patient, autoclaves which decontaminate waste and a dedicated laboratory
for carrying out tests, all of which help to ensure the patient can be treated
safely and securely.
ŸAll the air leaving the unit is cleaned so there is no risk to anyone at the
hospital.
31
Cardiology
Department of Cardiology at CIMS Hospital in Ahmedabad
is amongst the best angioplasty and angiography hospitals
in India, with a patient success rating amongst the highest in
the country.
CIMS is dedicated to provide cardiac patients the best
possible treatment and offers the latest and best-proven and
trusted medical processes and procedures to ensure the
highest possible success rate.
The hospital has a team of world renowned, experienced
and highly qualified cardiologists available 24×7 to attend to
all cardiac emergencies.
We follow the latest international AHA / ACC guidelines in
performing all cardiac procedures, which ensures the
patients are given the best cardiac care according to world
standards.
Salient Features
ŸOne of the largest group practice of cardiologists in the
country
ŸAll the latest international AHA (American Heart
Association)/ACC (American College of Cardiology)
guidelines are followed in diagnosis and treatment of
patients.
ŸDisease specific clinics include: Heart Transplant Clinic,
CIMS STEMI initiative, CIMS Heart Failure Clinic,
Structural and Valvular Clinic and STROKE Center,
Arrhythmia Clinic, Cardio Oncology Clinic
32
Cardiology
ŸHoused with 3 ultra-modern well-equipped Cath labs, to
cope with the high volumes
ŸRadial Lounge facility for patients
Ÿ7-second angiography
ŸInterventional Cardiology Coronary angiography
ŸCoronary angioplasty Peripheral & carotid angioplasty
ŸDevice therapy for heart failure
ŸBalloon valvuloplasty
ŸPercutaneous intervention for structural heart diseases
Cardiology Department at CIMS Hospital – Patient Rated as
the Best Cardiac Hospital in Ahmedabad with five star
reviews across multiple online review platforms for the
hospital overall in India!
Novel Technology at CIMS: Shockwave Intravascular
Lithotripsy
First ever in India in real world scenario three cases of
heavily calcified coronary arteries were successfully
intervened using “Trans Radial Intravascular Lithotripsy”
(Shockwave IVL)
Shockwave Intravascular Lithotripsy for managing the
challenging calcium buildup in coronary arteries arrived in
India after a long wait for improvising patient outcomes on
approval by the Drug Controller General of India (DCGI).
33
Cardiology
The Shockwave Intravascular Lithotripsy uses acoustic
sonic waves and the principle of lithotripsy which is created
on extremely low pressures to address the most challenging
calcium buildups.
The shockwave is administered by pressing the button of a
unique pulse generator which is attached to the console of
the system in just 30-40 seconds. The safe device allows
challenging the calcium with a few presses of the button.
The Shockwave Intravascular Lithotripsy is truly
groundbreaking, and we are proud of the fact that these
three were the first cases of Transradial Shockwave
Therapy in India. The conventional balloons had failed even
at extremely high pressures in these three cases and one of
three patients had been waiting for over a year for
preferential treatment to address the challenging calcium in
his coronary arteries.
In complex cases, the calcium residing for years or decades
in coronary arteries does not let the conventional balloons to
dilate the lesion and this leads to unsatisfactory results in
angioplasties performed. With the advent of shockwave, the
most complex lesions with hard calcium can be handled in a
much simpler way with least rates of adverse events.
With the advent of SHOCKWAVE the most complex lesions
with hard calcium can be handled in a much simpler way.
This simple technique of lithotripsy ensures lower risk of
adverse events which includes perforations/dissections
compared to conventional techniques.
Calcified long lesion
Intravascular Lithotripsy Shockwave Balloon
Highly Calcific Artery Stent being placed
34
Cardiology
Typical Indications for use of Intravascular Lithotripsy
ŸCoronary calcification noted on fluoroscopy or
noninvasive imaging (i.e. Computed Tomography
Coronary Angiogram)
ŸEvidence of an undilatable lesion despite high-pressure
noncompliant balloon dilatation as lesion preparation
ŸEvidence of heavy calcification noted on intravascular
imaging, either Optical Coherence Tomography or
Intravascular Ultrasonography.
Advantages
ŸProvides a more controlled means of calcium modification
ŸHas the ability to modify calcification without further vessel
injury with minimal trauma on soft tissue
ŸLess complications like noreflow/ slow flow and
perforation compared to atherectomy device.
ŸLess technically demanding compared with atherectomy
and hence has a short learning curve to become familiar
with the technology.
Procedural Steps to Perform Shockwave IVL
Advantages and disadvantages of Intravascular Lithotripsy compared
with other methods of calcium modification
Final Results
The IVL Catheter is delivered
across a calcified lesion over
an 0.014” wire and the
integrated balloon is
expanded to 4 atm to facilitate
efficient energy transfer
1
An electrical discharge from
the emitters vaporizes the
fluid within the balloon
creating a rapidly expanding
& collapsing bubble that
generates sonic pressure waves
2
After calcium modification,
the integrated balloon may
subsequently be used to
dilate the lesion at low
pressure in order to
maximize luminal gain
4
The waves creates a localized
field effect that travels
through soft vascular tissue,
selectively cracking intimal
and medial calcium within the
vessel wall
3
Cardiology
3834
45544755 4819 4892
3834 3830 37253455
0
1000
2000
3000
4000
5000
6000
2011 2012 2013 2014 2015 2016 2017 2018 2019
Angiography Volumes
35
No
. of
Pat
ien
ts
2576
879
0
500
1000
1500
2000
2500
3000
Male Female
Proportion of male patients in the age group of 51-60 years
undergoing angiography was higher than females in 2019.
Gender Distribution of Angiography Patients
No
. of
Pat
ien
ts
1298
1519
1683 1695 1687
14631574
14411344
0
200
400
600
800
1000
1200
1400
1600
1800
2011 2012 2013 2014 2015 2016 2017 2018 2019
Percutaneous Coronary Intervention at CIMS
Of the total angiographic investigations, about 30-35 % underwent Percutaneous Coronary Intervention (PCI). CIMS does some of the largest number of angioplasties amongst any centers in India.
No
. of
Pat
ien
ts97
210
341
430
201
65
0
50
100
150
200
250
300
350
400
450
500
< 40 yr 41 - 50 yr 51 - 60 yr 61 - 70 yr 71 - 80 yr = 80 yr
Age Distribution of Angioplasty Patients
Majority of patients who underwent catheterization were of age group of 61-70 years followed by 51-60 years. CIMS holds
the ability to perform interventional procedures in octogenarian (> 80 years) patients as well as pre mature CAD patients (< 55 years).
No
. of
Pat
ien
ts
158
605
11311087
399
75
0
200
400
600
800
1000
1200
< 40 yr 41 - 50 yr 51 - 60 yr 61 - 70 yr 71 - 80 yr = 80 yr
Age Distribution of Angiography Patients
No
. of
Pat
ien
ts
1064
280
0
200
400
600
800
1000
1200
Male Female
Gender Distribution of Angioplasty Patients
Proportion of males undergoing catheterization was higher as
compared to females.
No
. of
Pat
ien
ts
Cardiology
36
Single Vessel Disease
10401119
12921386
1288
10771180
11191046
0
200
400
600
800
1000
1200
1400
1600
2011 2012 2013 2014 2015 2016 2017 2018 2019
Single Vessel Disease
No
. of
Pat
ien
ts
Double Vessel DiseaseDouble Vessel Disease
240
354 355
286
330 325 320
270
230
0
50
100
150
200
250
300
350
400
2011 2012 2013 2014 2015 2016 2017 2018 2019
No
. of
Pat
ien
ts
Triple Vessel DiseaseTriple Vessel Disease
18
46
36
23
69
61
74 75
68
0
10
20
30
40
50
60
70
80
2011 2012 2013 2014 2015 2016 2017 2018 2019
At CIMS it has been very often to treat multi-lesions, bifurcation lesions,
calcified lesions and no option patients using high precision techniques
like IVUS and FFR.
No
. of
Pat
ien
ts
Cardiology
37
Radial Approach For Angioplasty
1173
1388
1585 1620 1662
14301541
13771326
0
200
400
600
800
1000
1200
1400
1600
1800
2011 2012 2013 2014 2015 2016 2017 2018 2019
At CIMS, our well experienced interventional cardiologists with technical expertise perform majority of procedures through radial approach
as compared to femoral approach.
No
. of
Pat
ien
ts
Advantages of radial approach:
ŸEase of catheter passage, even in overweight or obese
patients.
ŸThe patient does not require post-procedural
immobility.
ŸEarly ambulation and PCI can be performed as a
day care procedure.
According to AHA guidelines of PCI, compared to femoral
access, radial access decreases the rate of access-
related bleeding and local vascular complications.
ŸOver 30 years of experience in interventional cardiology.
Ÿ24 x 7 cardiac services with pioneer team of India for
Primary Angioplasty in Acute Myocardial Infarction (PAMI)
ŸCARTO-3 System : First time in Western India, state-of-
the-art Imaging System for Enhanced Visualization for
Treating Arrhythmia Patients.
ŸRadial Lounge, the first of its kind in the country - centrally
air-conditioned enclave with comfortable semi-
recliners chairs for patients, who may walk in for a
day care procedure (Radial Angiography).
Data comparison of door-to-balloon time (interval starts
with the patient's arrival in the emergency department and
ends when a catheter guide wire crosses the culprit lesion
in the cardiac Cath lab) presents CIMS Hospital
comparable to ACC and AHA Goals.
150
171
201185 180
189
236
159
199
0
50
100
150
200
250
2011 2012 2013 2014 2015 2016 2017 2018 2019
Primary Angioplasty in Myocardial Infarction (PAMI)
Various Risk Factors Among Angioplasty Patients
810
685
480
0
100
200
300
400
500
600
700
800
900
Hypertension Diabetics Smoking
Prevalence of hypertension and diabetes was
high among patients undergoing cardiac catheterization.
No
. of
Pat
ien
tsN
o.
of
Pati
en
ts
38
Cardiology
The ACC/AHA practice guidelines recommend PCI
(Angioplasty) balloon inflation within 90 minutes of
arrival in the emergency department for patients with
ST-Elevation Myocardial Infarction (STEMI). Early
reperfusion reduces the risk of morbidity and mortality. At
CIMS, we achieve this in less than 63 minutes on an
average.
The infrastructure and facilities at CIMS, averages length of
stay to about (39 hours) and half day after angioplasty - a
very short duration as compared to other healthcare
facilities.
Advances in Cardio Vascular Practice
ŸHeart Failure Clinic
ŸPulmonary Atrial Hypertension Clinic
ŸLipid Clinic
ŸStructural Heart Disease Clinic
ŸValvular Clinic
ŸHeart Transplant Center: We are the First hospital in
Gujarat (INDIA) to have completed successfully a
heart transplant
ŸPGRO:Helps cross cultural bridges between hospital and
patient to create a better interaction and smoother flow of
services
ŸThe Hospital to Home (H2H) and Hospital to Family (H2F)
program of CIMS takes care of patients after discharge
and counsels family members to take care against CAD
risk factors.
ŸCare at Homes: 24 hour complex clinical care at home
40
47
64 63 64 62 6460
63
90
0
10
20
30
40
50
60
70
80
90
100
2011 2012 2013 2014 2015 2016 2017 2018 2019 ACC/AHAGoal
Door to Balloon Time
Cardiology Average Length of Hospital Stay
1.73
1.56 1.55
1.491.51
1.581.6 1.59
1.66
1.35
1.4
1.45
1.5
1.55
1.6
1.65
1.7
1.75
2011 2012 2013 2014 2015 2016 2017 2018 2019
No
. of
Day
sT
ime i
n M
inu
tes
39
Cardiac Investigations
CIMS is well- equipped with latest technologies to help
make right treatment decisions. The well experienced
cardiology team and validated diagnostics offer best
treatment to its patients.
Non-invasive diagnostic cardiology services at CIMS
include:
ŸElectrocardiography (ECG)
ŸTreadmill Test (TMT)
Ÿ2D-Echo and 3D-Echo with Color Doppler
ŸAdenosine and Dobutamine Stress 2Decho
ŸTrans-Esophageal Echocardiography (TEE)
ŸHolter Monitoring
Ÿ24 hour Ambulatory Blood Pressure Monitoring
ŸEvent Recorders and King of Heart Loop Monitor
ŸTilt Table Test / Head up Tilt Test
ŸSignal averaged ECG
ŸNon-Invasive EP Study (NIEPS)
40
Cardiac Investigations
Pic of Pacemakers or Defibrillators
41
Cardiac Rhythm Disorders
CIMS offers various treatments for Cardiac Rhythm
Disorders
Electrophysiology Procedures
ŸElectrophysiology studies (EPS) for diagnosis of cardiac
arrhythmia (conventional and 3-Dimensional mapping
system)
ŸRadiofrequency Ablations (RFA) of complex Cardiac
Arrhythmias
ŸPacemaker Implantation
ŸBiventricular pacing (CRT - Cardiac Resynchronization
Therapy) for Heart Failure
ŸAutomatic Implantable Cardioverter Defibrillator (AICD)
implantation
ŸComprehensive Device follow-up Clinic (Pacemaker,
CRT, AICD)
Carto-3 Systems
ŸElectroanatomic Mapping System, state-of-the-art
imaging system offers enhanced visualization for
treating arrhythmia patients.
ŸAt CIMS, patients with EF <35% were also evaluated
for risk of sudden cardiac death and a need for ICD. All
patients implanted with defibrillators were followed up.
These patients have successfully survived sudden
cardiac arrest episodes due to VT/VF.
42
Cardiac Rhythm Disorders
43
Cardiac Thoracic Surgeries
CIMS Cardiac Surgeons treat infants and geriatric patients
with equal expertise. With over 10,000 Cardiac Thoracic
surgeries completed with outstanding post operative
results, CIMS Cardiac Surgery is one the most trusted Heart
Surgery center of the State.
Cardiac Surgery
ŸHeart Transplant
ŸCongenital Heart Surgery
ŸLung Transplant
ŸMitral Valve Repair
ŸSingle and Double Valve Replacement
ŸAortic Root Replacement
ŸOff Pump CABG (Coronary Artery Bypass Grafting) on
Beating Heart
ŸMICS (Minimally Invasive Cardiac Surgery) CABG for LV
(Left Ventricular) dysfunction
ŸCombined Carotid and Bypass Procedure
ŸMinimal Invasive Cardiac Surgery (MICS)
44
Cardiac Thoracic Surgeries
Our Cardiovascular Surgical Team of experts provide advanced care while
listening, explaining and working together to achieve high success rates
CIMS Cardiac surgeons successfully perform surgeries on octogenarians. It holds the credit of performing cardiac surgery on >80 year old patients. Premature CAD (Age < 50 years) was treated in more than 100 subjects.
Although prevalence of CAD is higher in males as compared to age matched
females, outcomes are poorer in females as compared to males. Prevalence of
CAD has increased in young females probably because of small vessels
severe disease and less responsive healing tissues.
In adult patients 50% patients have normal ejection fraction. But significant number
of LV Dysfunction patient following surgery show excellent long term outcomes.
At CIMS almost 93 % of CABG ‘Off pump’ beating heart is performed.
Even LV Dysfunction and dilated heart can undergo beating heart surgery. CABG on
beating heart improves the postoperative recovery and has been a preferred technique
in patient with renal failure, COPD and old age. It reduces prevalence of stroke.
Co-Morbidity among Patients Undergoing CABG
45
Cardiac Thoracic Surgeries
Management Strategies for CABG Patients To Reduce Mortality and Morbidity:ŸPre-operative complete evaluation of the patientŸTo Continue Aspirin till the date of SurgeryŸPeri-operativetrans-oesophageal evaluation of all patientsŸDoing maximum number of “Off pump” CABGs for better and
faster recoveryŸTo use maximum number of arterial graftsŸContinuous Cardiac output and hemodynamic monitoring in
the ICUŸFast-tracking protocols in ICU for early mobilization and
recoveryŸPost-operative physiotherapy and Dietary Counseling and
advisingŸPsychotherapy Evaluation and management during post-
operative period
46
Heart Failure
Our heart failure team is dedicated to excellence in
specialist and evidence-based heart failure care.
Our team is made up of a variety of health care professionals
from various disciplines. Including highly trained
cardiologists, heart failure registrars, specialist heart failure
nurses and a dedicated heart failure therapy team with a
specialist physiotherapist, heart failure dietician,
occupational therapist and heart failure pharmacist.
We have also the heart rhythm team for complex heart
rhythm management and device implantation, which may
help in heart failure such as advanced pacemakers and
defibrillators.
There is also ready access to the extended multidisciplinary
team such as the pulmonary hypertension service, palliative
care, cardiac rehabilitation.
11
15
33
28 29
2422
11
6
0
5
10
15
20
25
30
35
2011 2012 2013 2014 2015 2016 2017 2018 2019
Total Volume of CABG + MV Repair
Nu
mb
er
of
Pati
en
ts
241
266 1 2
0
50
100
150
200
250
300
CABG Valvular Surgery CABG+MVRepair
CABG+VSD Heart Transplant
Different Surgeries for Heart Failure 2019 (N=277)
Nu
mb
er
of
Pati
en
ts
47
Cardiac Valve Disorders
CIMS Hospital standard protocol for the treatment of
valvular heart disease:
• A course of antibiotics is prescribed prior to surgery or
dental work for those with valvular heart disease, to prevent
bacterial endocarditis.
• Long-term antibiotic therapy is recommended to prevent
recurrence of streptococcal infection in those who have had
rheumatic fever.
• Antithrombotic (clot-preventing) medications such as
aspirin or ticlopidine may be prescribed for those with
valvular heart disease who have experienced unexplained
transient ischemic attacks, also known as TIAs.
• More potent anticoagulants, such as warfarin, may be
prescribed for those who have atrial fibrillation (a common
complication of mitral valve disease) or who continue to
experience TIAs despite initial treatment.
• Long-term administration of anticoagulants may be
necessary following valve replacement surgery, because
prosthetic valves are associated with higher risk of blood
clots.
• Balloon dilatation (a surgical technique involving
insertion into a blood vessel of a small balloon that is led via
catheter to the narrowed site and then inflated) may be done
to widen a stenotic valve.
• Valve Surgery to repair or replace a damaged valve may
be necessary. Replacement valves may be artificial
(prosthetic valves) or made from animal tissue
(bioprosthetic valves). The type of replacement valve
selected depends on the patient’s age, condition, and the
specific valve affected.
• Prevention tips for a heart-healthy lifestyle.
48
Minimal Invasive Cardiac Surgery
Different Procedures under Minimally Invasive Cardiac
Surgery (MICS) are offered at CIMS.
MICS can treat many kinds of below heart complexities
• Coronary Artery Bypass Grafting(CABG)
• Mitral Valve Repair & Replacement
• Aortic Valve Repair & Replacement
• Bental Procedure – Replacement of Aortic Valve, Aortic
Root & Ascending Aorta
• Replacement of Aortic Root
Benefits of MICS:
• Small 2 to 3-inch incision, no bone separation
• 3 to 5 days hospitalization
• Recovery in 10 days
• No use of heart-lung machine
• Reduced possibility of infections, ideal for old, diabetic
patients
• Smaller incisions and fewer scars
• Less bleeding, less blood transfusion
• Less pain and discomfort after surgery
• Less trauma to the breastbone – improved breathing
• Shorter hospital stay
At CIMS, mortality rates for patients, who had CABG plus
other procedures with CABG was around 2 % which is lower
than expected rate, despite the fact that nearly all patients
were sick and most of them had severe LV dysfunction.
Average length of hospital stay following cardiac surgery is 7.9 days which is relatively low.
49
Paediatric Cardiac Sciences
CIMS Hospital offers below listed services to provide state
of the art treatment for the pediatric patients with heart
disease:
• Pediatric Cardiology and Pediatric Cardiac Surgery
• Full time dedicated pediatric cardiologists
• State-of-the-art echocardiography machine with
pediatric 3D imaging and applications
• Pediatric / infant transesophageal echocardiography
• Pediatric hypertension / arrhythmia / CHF clinics
• Complete range of neonatal and pediatric interventions
• Pediatric cath lab with ICU for 'after care'
• Neonatal and pediatric cardiac intervention
• Non-surgical closure and surgery for ASD (Atrial Septal
Defect), VSD (Ventricular Septal Defect), PDA (Patent
Ductus Arteriosus)
• Surgery for TOF (Tetralogy of Fallot)
50
Vascular and Endovascular Surgery
We have the best endovascular surgeons and assisting
team to manage the most complex cases.
Treatment Options Include
• Non-surgical treatment for leg vessels
• Treatment of varicose veins
• Angioplasty for peripheral vessels
• Stroke prevention by medical, percutaneous and
surgical interventions
• Open repair of blood vessels from heart to different areas
of body
• Diabetic foot care clinic
• Dialysis access procedures
• Limb vessel intervention (above and below the knee)
• Deep vein thrombosis
51
Vascular and Endovascular Surgery
Vascular Average Length of Hospital Stay
52
Thoracic Surgery
The Department of Thoracic Surgery is solely dedicated to
the prevention, early diagnosis and treatment of diseases of
the chest and for non-cardiac thoracic diseases. The
hospital has some of the best doctors who are leaders in
surgical treatment of patients with simple and complex
thoracic conditions ranging from lung cancer, emphysema,
esophageal cancer, and mediastinal diseases and other
chest diseases. The department offers latest techniques
such as, bronchial and esophageal stents, minimally
invasive surgical procedure, laparoscopic and
thoracoscopic surgery, and video-assisted thoracic surgery
(VATS).
Conditions treated include:
• Lung preserving surgeries
• Various types of lung resection
• Lung cancer surgery
• VATS (Video Assisted Thoracoscopic Surgery)
• Redo-thoracic surgery (revised surgery after
unsuccessful previous surgery)
• Airway surgeries
54
Our specialists and well-trained surgeons at CIMS Hospital
are world-renowned for developing and implementing state-
of-the-art techniques to diagnose and treat bone and joint
disorders. Our main aim is to provide the highest level of
care available so that we may return our patients to their
daily activities as quickly as possible.
Orthopedic surgeries and treatments carried out at
CIMS include:
ŸJoint replacement, Knee, Hip, Shoulder and Elbow
Replacement
ŸRevision knee and Hip replacement surgery
ŸComplicated intraarticular and periarticular factures
ŸComplicated poly trauma and high risk orthopedic
surgery
ŸArthroscopic surgery
ŸArthroscopic reconstruction
ŸFracture care
ŸSports surgery
ŸSpine and back injury treatment
ŸFoot and ankle injury treatment
ŸHand, Wrist and Upper extremity care
We take pride in offering full spectrum of musculoskeletal
conditions from sprains and strains; limb sparing oncology
procedures; from carpel tunnel syndrome to complex spinal
reconstruction.
Orthopaedic Surgery
55
Facilities
The Orthopedics clinic at Care Institute of Medical Sciences
are equipped with advanced innovative technology, like:
• Highly skilled, qualified and experienced orthopedic
surgeons
• Protocol based treatment
• Orthopedic operation theatres equipped with best
available gadgets in the industry
• State-of-the-art equipment’s
• Image intensifiers, Digital X-ray,64 slice CT, 1.5 Tesla
MRI
• Well-equipped ICU for postoperative care
• Very low incidence of postoperative infection
• Excellent backup of physiotherapy services
• Dedicated orthopedic theatres
• Computer navigation system
• Arthroscopic equipment for all joints,
• High definition cameras
• Dedicated anesthesiologists team
• Dedicated OT staff and orthopedic nursing staff
• Excellent clinical outcomes of high tech orthopedic
procedure
Orthopaedic Surgery
56
Pediatric Orthopedics
We treat children and young adults with a wide range of
developmental disorders, congenital, neuro muscular and
post traumatic problems with bone joints and tendons. We
provide surgical and non-surgical treatment for conditions
including, but not limited to:
• Spinal disorders, including scoliosis, kyphosis,
spondylolysis, and back pain
• Hip diseases like dysplasia, slipped capital femoral
epiphysis, and avascular necrosis
• Cerebral palsy and other neuromuscular conditions
• Congenital anomalies/birth defects of the extremities
• Leg length differences
• Club feet
• Trauma and growth disturbances
• Bone tumors (sarcomas)
Centre for Rehabilitation for Orthopedic Patients
Our rehabilitation department is equipped with modern
facilities like gait analysis, electrotherapy equipment and
state-of-the-art gym for rehabilitation. Our team of surgeons
are supported by experienced and motivated Rehabilitation
consultant, Physiotherapists and occupational therapist
who provide personalized care or tailor made care to each
and every out-patient, in-patient as and when required.
The institute has qualified; skilled doctors and surgeons
trained in India and abroad who offer excellent outcomes.
The orthopedic team diagnoses, operates and treats
problems affecting the bones, joints and muscles of patients
in all age groups. Our orthopedic surgeons are recognized
amongst the best in the country.
Orthopaedic Surgery
Knee Replacement Hip Replacement
Shoulder Replacement Elbow Replacement
Orthopaedic Average Length of Hospital Stay
57
Pulmonary Medicine
CIMS houses specialists in pulmonary and sleep medicine
having expertise in treating people with a wide range of
diseases and conditions affecting the lungs and breathing.
CIMS pulmonologists are part of an integrated team of
highly specialized medical and surgical experts who work
together to care for people of all ages.
CIMS pulmonary medicine team works closely with
colleagues who specialize in thoracic surgery, critical care,
sleep medicine, pediatric sleep medicine, allergy and
immunology, lung transplant, and others areas. This
tradition of collaboration helps to ensure individualized
treatment plan that considers all needs and all aspects of the
pathology.
Following diseases are diagnosed and
treated at CIMS hospital:
ŸAsthma
ŸSleep Apnea
ŸChronic Cough
ŸChest pain
ŸCOPD
ŸPulmonary & extra pulmonary TB
ŸInterstitial Lung Disease
ŸOccupational Lung Disease
ŸPlural Effusion
ŸPneumonia
ŸLung Cancer
Facilities Available include :
ŸSpirometry
ŸPlethysmography test
ŸDiffusion capacity test
ŸSleep Study
ŸThoracoscopy
ŸBronchoscopy
ŸEBUS (Endobronchial ultrasound)
ŸEndobronchial Stenting
Pulmonology Average Stay Length of Hospital Stay
58
Neuro and Spine Surgery
Neurosurgery is specially concerned with the diagnosis and
treatment of disorders of the nervous system, which
includes the brain, skull, spine & spinal cord.
At CIMS, state-of-the-art neuro surgical and micro neuro-
surgical techniques are employed to treat and alleviate pain
and disability caused by neurological problems.
A highly qualified and skilled team of neurosurgeons along
with neuro-physician an efficient team of anesthesiologists,
nurses, neuro physiotherapist and medical staff guide the
patient through the entire process aiding a smooth
procedure and recuperation.
Procedures like Spine Trauma, Head Injuries, Poly trauma,
Spine Surgery, Brain Tumor surgery, Disk surgeries,
Endovascular Neurosurgery, Micro Neurosurgery, Neuro
Vascular surgery, Stereotactic Neurosurgery, Endoscopic
Neurosurgery are routinely performed at CIMS with high
success rate.
Pediatric Neurosurgery
ŸHydrocephalus: Endoscopic ventriculostomy, shunt
surgery
ŸPaediatric brain and spine tumor surgery
ŸSpinal dysraphism and tethered cord surgery
ŸCraniosynostosis correction
Skull Base Surgery Services:
ŸSkull base tumor excision: acoustic neuromas,
chordomas
ŸCerebro spinal fluid leaks
ŸCraniofacial deformities
ŸCranial base osteomyelitis
ŸMicro vascular decompression for trigeminal neuralgia,
hemifacial spasm.
ŸOccipito cervical decompression for chiari malformation.
59
Neuro and Spine Surgery
ŸSpinal Tumor, Vascular Malformation Excision:
Vascular anomalies are divided into two groups: Tumors
and Malformations. Vascular Tumors are large and
complex group of lesions.
ŸPercutaneous Vertebroplasty and Kyphoplasty for
Spine Fractures: Both Vertebroplasty and Kyphoplastry
are minimal invasive procedure used to treat vertebral
compression fractures (VFC) of the spine. These are
caused due to major injury but are very painful and
wedged shaped.
ŸCervical and Lumbar Artificial Disc Replacement
Surgery: Artificial Disc Replacement is for those patients
who have back pain which cannot be managed by
conservation treatment.
ŸCorrection of Scoliosis and Other Deformities:
Scoliosis is an abnormal curvature coronal plane that can
occur in children, adolescents and adults.
ŸSpine Stabilization: Spondylolisthesis, Koch’s Spine,
and Traumatic Fractures: These occur when there is
weight bearing structure of the body, which segments the
surrounding protective discs.
ŸSpasticity Surgery (Baclofen pump): When the
problem with cerebral palsy arises in children and adults,
spasticity of arm and hand can lead to pain, stiffness and
loss of use.
ŸSpinal cord stimulator for Chronic Pain (Morphine
Pump): Spinal Cord stimulator also known as
Neurostimulation directs the mild electrical pulses to
interfere with pain signals to the brain cells. This small
device is implanted near the spine where the stimule is
generated.
Brain Surgery services:
ŸBrain tumor surgery
ŸMicroscopic/ endoscopic transnasal pituitary tumor
excision
ŸNeuro Vascular lesions: Aneurysm, AVM
ŸStroke surgery: brain hemorrhage, carotid endartrectomy
ŸStereotactic surgery
ŸCranioplasty
ŸEpilepsy surgery
ŸCranial and brain trauma
Our Spine Surgery Service includes:
ŸMinimally Invasive Spine Surgery (MISS): Micro
D iscec tomy, Decompress ion , Laminec tomy,
Laminoplasty and Spine fusion. This is through a
specialized instrument to access the spine through small
incisions.
60
Trauma Center
The Emergency & Trauma Care division at CIMS constitutes
a team of highly specialized physicians & surgeons. The
Center Is accredited by the Joint Commission, the quality
gold standard or a national accreditation body such as the
NABH.
Critically ill patients due to sickness or patients who are
injured severely by life-threatening events & fatal poisoning
are immediately taken under the care and resuscitated,
stabilized & managed as per the international protocols.
Trauma Facility Centers are broadly classified into 5 levels
on the basis of the quality of care they offer. CIMS is Level-1
Trauma Facility, which means it provides the highest level of
specialty expertise and meets strict standards as it has in-
house surgical specialists and sub-specialists which
includes :
• Trauma Surgeons
• Neurosurgeons
• Orthopedic surgeons
• Plastic surgeons
• Spine Surgeons
• Vascular Surgeons
• Anesthesiologists
• Rehabilitation Medicine
61
Trauma Center
In an effort to deliver excellent care, our emergency
department follows international protocols in-
Acute care management,Particularly for heart attack(MI),
Stroke, Abdominal emergencies and Polytrauma.
Salient Features of Trauma Center
• Data has been collected and reviewed monthly to ensure
continuous improvement in quality of care.
• “Every patient to the right clinician at the right c l i n i c a l
setting” is our driving force and our source of
inspiration towards high quality patient care and
treatment.
• Our priority is to ensure that all patients are cared in a
way that is safe, effective and efficient, and we strive to
provide high-quality services for better clinical
outcomes.
• The Center manned by ACLS Certified postgraduates, is
capable of handling all type of emergencies.
• The Centre has Cardiovascular Life Support
Ambulances equipped with essential life support system
and is manned by trained doctors and nurses round the
clock
• The world-class trauma facility is operational 24x7.
International standards and protocols are
followed at the CIMS Hospital Emergency Unit.
62
Gastroenterology and General Surgery
CIMS Hospital launched the Institute of General Surgery
and Surgical Gastroenterology to provide the highest level
of healthcare in this specialty, while being affordable and
accessible for the general population.
CIMS offers day care surgeries and procedures in this
specialty with sophisticated operation theatres, experienced
surgeons and trained support staff. The largest operative
group of day care surgeries are related to the gall bladder,
pancreas, hernias, piles (haemorrhoids) skin and soft
tissues.
General and Gastrointestinal Conditions Treated
• Acid reflux (GERD)
• Chronic Constipation Morbid Obesity
• Gallstones
• Gastrointestinal obstruction and bleeding
• Gastrointestinal cancer
• Inflammatory bowel disease
(Ulcerative colitis & Crohn disease)
• Hernia
• Hemorrhoids
• Diverticulitis
• Skin cancer
• Varicose veins
63
At CIMS Hospitals Gastroenterology services division
specializes in the prevention, diagnosis and treatment of
disease of the liver and digestive tract / system, including the
stomach, duodenum, gallbladder, biliary tract, pancreas,
small intestine and colon.
The department has a multi-disciplinary team involving
medical, surgical and radiological expertise.
The Department is well equipped to perform various
procedures like endoscopy, colonoscopy and is well
supported by round the clock laboratory, ICU, Radiology and
emergency services to ensure that patients receive highest
level of care in a timely manner.
Endoscopy can greatly help in early detection of Cancers to
insertion of Stents in Advanced Cancers, Bleeding from GI
tract and routine GI problems.
CIMS Hospital is having best Endoscopy unit equipped with
advanced Endoscopy System and trained technicians along
with skilled Endoscopes to diagnose and treat Gastro
Intestinal emergency medical situations like blood vomiting,
foreign body ingestion, hepatic coma etc.
Treatments and Procedures Performed in CIMS
Endoscopy is routinely performed at the Centers for Medical
and Surgical Gastroenterology, CIMS Hospitals, India for
the following conditions:
ŸFor patients who suffer from gastrointestinal bleeding,
both Banding / injection of esophageal varices and control
of bleeding with adrenaline injection are routinely
performed.
ŸFor patients with swallowing difficulty due to esophageal
stricture or achalasia, endoscopic dilatation can be carried
out under fluoroscopic guidance. Similarly, dilatation of
pyloric and colonic strictures can also be carried out. In
patients with esophageal tumors, metallic stent placement
is done, after dilatation.
Endoscopy
Endoscopy: Gastrointestinal Disorder
64
ŸFor patients for whom feeding is a problem either due to
neurological disorders or altered consciousness levels,
endoscopic placement of nasojejunal tube or PEG
(Percutaneous Endoscopic Gastrostomy) tube is done.
ŸEndoscopic removal of gastric / colonic polyps is routinely
done.
ŸFor patients with obstructive jaundice, ERCP / papillotomy
/ stone extraction from CBD/biliary stenting (plastic as well
as metal stents) is performed.
ŸPlacement of pancreatic stents in patients with severe
pain due to chronic calcific pancreatitis is done.
ŸEsophageal manometry, pH studies and rectal
manometry, which are available in only limited centers, are
done routinely and help not only in diagnosis, but also in
deciding which patients with gastroesophageal reflux or
achalasia are likely to require surgery.
ŸOther routine procedures like liver biopsy, aspiration of
liver abscess and diagnostic and therapeutic paracentesis
are done through endoscopy.
Endoscopy
Endoscopic Ultrasound
Endoscopic ultrasound (EUS) is a minimally invasive
procedure to assess digestive (gastrointestinal) and lung
diseases. A special endoscope uses high-frequency sound
waves to produce detailed images of the lining and walls of
your digestive tract and chest, nearby organs such as the
pancreas and liver, and lymph nodes.
EBUS can help:
ŸAssess how deeply a tumor penetrates your abdominal
wall in esophageal, gastric, rectal, pancreatic and lung
cancers
ŸDetermine the extent (stage) of cancer, if present
ŸDetermine if cancer has spread (metastasized) to lymph
nodes or other organs
ŸProvide precise information about non-small cell lung
cancer cells, to guide treatment
ŸEvaluate abnormal findings from imaging tests, such as
cysts of the pancreas
ŸGuide drainage of pseudocysts and other abnormal
collections of fluid in the abdomen
ŸPermit precise targeting for delivering medication directly
into the pancreas, liver and other organs
65
Oncology
CIMS Hospital’s department of Oncology offers Cancer
Detection, Counselling and in-total disease management. We
have been performing chemotherapy with both conventional
and newer, globally accepted protocols of chemotherapy.
ŸCIMS Hospital, Ahmedabad has an advanced Digital
Mammography System for Breast Cancer screening; the
benefits of digital mammography are various Complex tumor
excision surgeries are routinely performed.
ŸWe have a team of highly skilled, well trained and
experienced team of Surgical Oncologists supported by an
extensively trained & skilled operating theatre and post-op
intensive care staff; in totality we ensure that the success rate
of Oncology surgeries is comparable with that of the best
hospitals globally.
ŸA medical oncologist treats cancer using chemotherapy or
other medications, such as targeted therapy or
immunotherapy. A surgical oncologist removes the tumor and
nearby tissue during surgery.
ŸCIMS Hospitals' comprehensive care is supported by
technology and innovative techniques in High Precision
Radiation oncology. High tech radiation oncology is used to
treat not only small tumors located in critical areas but is
useful in large tumors as well. Experts at CIMS, from a range
of disciplines, come together to assess a patient's suitability
for the therapy, which is delivered using a number of
precisely-targeted stereotactic beams. The 4-dimensional
CT scanner is useful in planning treatment to track the
tumor’s position as it moves when the patient breathes,
guaranteeing a high degree of accuracy and potentially fewer
side effects by limiting irradiation of the surrounding normal
tissues.
66
Oncology
Sub-specialties in Oncology
ŸNeuro-oncology: focuses on cancers of brain.
ŸOcular oncology: focuses on cancers of eye.
ŸHead & Neck oncology: focuses on cancers of oral cavity, nasal
cavity, oropharynx, hypopharynx and larynx.
ŸThoracic oncology: focuses on cancers of lung, mediastinum,
esophagus and pleura.
ŸBreast oncology: focuses on cancers of breast
ŸGastrointestinal oncology: focuses on cancers of stomach,
colon, rectum, anal canal, liver, gallbladder, and pancreas.
ŸBone & Musculoskeletal oncology: focuses on cancers of
bones and soft tissue.
ŸDermatological oncology: focuses on the medical and surgical
treatment of skin, hair, sweat gland, and nail cancers
ŸGenitourinary oncology: focuses on cancers of genital and
urinary system.
ŸGynecologic oncology: focuses on cancers of the female
reproductive system.
ŸPediatric oncology: concerned with the treatment of cancer in
children.
ŸHemato oncology: focuses on cancers of blood and stem cell
transplantation
ŸPreventive oncology: focuses on epidemiology & prevention of
cancer.
ŸGeriatric oncology: focuses on cancers in elderly population.
ŸPain & Palliative oncology: focuses on treatment of end stage
cancer to help alleviate pain and suffering.
ŸMolecular oncology: focuses on molecular diagnostic methods
in oncology.
ŸOnco pathology: A specialty of Pathology that focuses on the
histopathological diagnosis of cancer. As a significant portion of
all general pathology practice is concerned with cancer, the
practice of oncology is deeply tied to, and dependent upon, the
work of both anatomical and clinical pathologists.
ŸNuclear medicine oncology: focuses on diagnosis and
treatment of cancer with radiopharmaceuticals.
ŸPsycho-oncology: focuses on psychosocial issues on
diagnosis and treatment of cancer patients.
ŸVeterinary oncology: focuses on treatment of cancer in animals
Onco Services
ŸQuick and Easy procedure
ŸReduced discomfort to the patient
ŸLower radiation dosage
ŸBetter accuracy, particularly in the age group 40 - 50 years
ŸAll images are archived and stored digitally, hence no loss or
damage of films
ŸSince it is digital, it can be sent electronically to other center’s
for another opinion
ŸStoring digitally creates an enormous database, which is
useful to teach and train the younger generation
Oncology Average Length of Hospital Stay
67
Nephrology
The Department of Nephrology provides comprehensive
care across the spectrum of kidney diseases. Our team of
experienced doctors is recognised for their superior clinical
skills and treats all categories of patients from children to
elders. CIMS houses an eminent team of kidney transplant
specialists, nephrologists, urologists and the technical
expertise needed to meet the challenges of this life saving
procedure. We offer the most advanced diagnostics,
comprehensive pre-operative evaluation and dialysis
support, the latest facilities available in surgical procedures,
and complete post-operative care to minimize chances of
infection.
We provide dialysis service driven by an efficient team of
nephrologists, nurses, and certified haemodialysis
technicians along with registered dieticians.
Peritoneal, nocturnal and short daily dialysis and
haemodialysis are provided to both children and adults.
The departments transplant facilities are engineered to
deliver quality care and successful outcomes even in ABO
incompatible transplants.
The state-of-the-art dialysis units with modern equipment
and facilities for nephrology treatment operates 24/7 at full
capacity in CIMS. Different services offered by the
nephrology department include-
• Continuous Renal Replacement Therapy (CRRT)
• Peritoneal Dialysis (CPD)
• Plasma Dialysis (Plasmapheresis)
• Liver Dialysis (MARS Therapy)
• Kidney Transplant
• Combined Kidney & Liver Transplant and Kidney Biopsy
At CIMS, 10 renal transplants have been successfully
performed till date.
Technological advancements have a lot of impact on the
Quality of Life. Life has been made simpler and better. In
nephrology many techniques have been established for the
creation of artificial kidney, and for the surgeries.
• Conventional dialysis replaced bio artificial technologies
• Stem cell
• Bioengineering approaches
• Nanotechnology for implantable kidneys
• Regenerative therapies
• Laparoscopic Nephrectomy
• Neobladder Construction
68
Urosurgery
The Department of Urology at CIMS offers advanced urological
care at par with quality based international standards. • Urinary Incontinence
• Urinary Tract Infections (UTIs)
• Bladder diverticulum
• Hematuria (blood in the urine)
• Erectile dysfunction (ED)
• Interstitial cystitis (also called
painful bladder syndrome)
• Overactive bladder
• Prostatitis (swelling of the
prostate gland)
• Urology cancers
• Prostate diseases
• Hernia surgery
• Laproscopic urology
• Reconstructive urology
surgery
• Stone disease
• Paediatric urology
• Paediatric renal transplant
and andrology
• Uroflorometry
• G e n i t o - U r i n a r y
Tuberculosis
We offer full spectrum of diagnostics and treatment for
Urology Average Length of Hospital Stay
The Plastic, Aesthetic & Reconstructive Surgery division at
CIMS is one-of-a kind, ultra-modern facility that combines
plastic surgery with the ancillary disciplines to make sure that
the patients receive holistic care.
The highly experienced and qualified team of experts and the
impeccable blend of technology and intelligence are committed
to provide patients with unparalleled results at accessible
prices.
The Department of Plastic Surgery offers comprehensive care
in all forms of cosmetic and reconstructive surgery. Areas of
interest and expertise include aesthetic surgery, breast surgery
and reconstructive surgery.
CIMS plastic surgeons team with surgeons in dermatology,
otolaryngology (ENT) and oral/maxillofacial surgery and
physicians to offer a comprehensive restoration.
Services available at CIMS include:
• Clefts of Lip and Palate Hypospadias
• Polydactyl
• Syndactyl
• Limb Defects
• Micro Vascular Surgery
• Hand Surgery
• Faciomaxillary Injuries
• Esthetics surgery in the form of Rhinoplasty
• Traumatic injury
• Congenital abnormality
• Developmental Abnormality
• Burns
• Infectious Disease
• Functional Impairments
We regularly treat patients, surgically and non-surgically, with
wounds resulting from diabetes, atherosclerosis, peripheral
vascular disease, neuropathy, radiation, venous stasis, trauma,
surgery, and many other conditions that lead to difficult wound
healing. These diverse, multidisciplinary capabilities are
enhanced by our access to state-of-the-art wound care
69
Plastic Surgery
70
Obstetrics and Gynecology
Salient Features :
ŸTeam of highly qualified gynecologists, IVF specialists,
obstetricians, counselors, providing best possible
healthcare to women.
ŸAn experienced panel of gynecologists providing best
quality ante-natal care to expectant mothers.
ŸMedical management of hormonal disturbances, delayed
menarche, menopausal complaints available on
outpatient basis.
ŸTreatment of female infertility done using advanced
surgical methods and through medical management.
ŸFetal medicine specialists utilizing advanced techniques
to monitor fetal growth and wellbeing.
ŸSpecialized laparoscopic (Endoscopic), Gynec Surgeries
such as Laparoscopic Assisted Vaginal Hysterectomy
(LAVH), Total Laparoscopic Hysterectomy (TLH),
Laparoscopic ovarian cyst removal, Laparoscopic Radical
Hysterectomy
ŸRemoval of Fibroid from uterus, non-descent vaginal
hysterectomy, abdominal hysterectomy, ovarian cyst
removal.
ŸManagement of Menopause
o Menstrual problems
o Pelvic pain
o Premenstrual symptoms
o Sexual concerns
o Breast diseases and menopause health issues
71
CIMS offers advanced treatment for conditions
including:
ŸChronic lung disease
ŸComplex surgical conditions
ŸCongenital heart disease
ŸLow birth weight
ŸNeurological complications including seizures and stroke
ŸPrematurity complications
ŸRare diseases
ŸSevere medical illness
Our expert team provides ongoing evaluation and care for
babies who are at risk for developmental issues related to
conditions treated for in a neonatal intensive care unit
(NICU). Our Newborn Follow-Up Program offers ongoing
care to ensure we meet the child’s special medical needs for
growth and development.
Neonatal Center
Total Volume of Non Cardiac Paediatric Surgeries
Age Distribution in Non Cardiac Paediatric Surgery
Gender Distribution in Non Cardiac Paediatric Surgery
72
ENT
Conditions Treated by an ENT Specialist at CIMS
Swollen Adenoids: Frequent throat infections can lead to
enlarged adenoids. Enlarged adenoids can cause difficulty in
breathing and block the Eustachian tubes, which connect the
middle ear to the back of the nose.
Sinusitis: Inflammation of the sinuses result in a plugged nose
and thick nasal mucus accompanied by pain in the face.
Tinnitus: A condition wherein an individual hears sound when
no external sound is present.
Nasal Airway Obstruction: A condition in which the airflow in
and out of the nose is hindered and affects one or both nasal
passages. It is caused by either swelling of the nasal tissue or
an anatomical blockage which results in narrowing of the nasal
cavity and congested sensation in the nasal passage.
Tonsillitis: Swelling of the tonsils caused due to a viral infection
or bacterial infections such as strep throat.
Eardrum Perforation: A tear or hole in the eardrum which can
result in hearing loss. This condition can also make the middle
ear more prone to infections or injury.
73
Pain Management
In India, “pain management” is a sub specialty of
anesthesiology branch.
CIMS pain management clinic provides comprehensive
care for people living with chronic pain, for whom medication
& other therapies are ineffective. The cause of pain is
thoroughly analyzed by qualified pain physicians &
treatment options given accordingly
At CIMS pain management clinic, we use best of the
Equipment’s Brands known in the category like Karl - Storz,
Cosman, Philips, Remi Lab , St. Judes etc. We use
equipment’s which are safe and give best results.
At CIMS, we treat following conditions:
• Low Back Pain
• Prolapsed or slipped disc
• Trigeminal Neuralgia
• Neck pain
• Knee pain
• Frozen shoulder
• Sports injury pain
• Cancer Pain
• RPS type I and II
• Neuropathic pain
• Vascular pain
• Muscular pain
• Headache or migraine
• Regenerative Pain Treatment
E.g. P.R.P. Injection
A2M, BMAC
Radio Frequency Machine
Spinal cord Stimulation Vertebroplasty
74
Dentistry
Dental Implants:
At CIMS, we improve the quality of life with DENTAL
IMPLANTS
1. Improved aesthetic
2. Preserved facial structure
3. Improved chewing function and confidence
4. Improved dental hygiene
5. Replacement of a whole missing tooth (root)
6. Avoiding the need to prepare adjacent teeth, since a
conventional bridge is not used
Dentistry for cardiac patients:
Special care should be taken for patients who
have cardiac disease and need dental treatment. We
do all dental treatment safely for cardiac patients.
We excel in providing dental treatment to patients with
serious cardiac diseases like: Valvular heart disease (with
ACC/AHA Guidelines).Cardiac failure or heart
attacks.Arrhythmias or implanted pacemaker Implanted
coronary stents and on antiplatelet/anticoagulant
treatment.Procedures to these patients are done
under continuous cardiac/NIBP and SpO monitoring on 2
dental chair only.Backup support of cardiologist / intensivist /
physician.
Cleft Lip and Palate:
Cleft Lip and Palate is one of the commonest birth
defects found in new-born babies. It is an entirely correctable
deformity and surgery is the only choice of treatment.
We provide comprehensive treatment to Cleft children with
our multidisciplinary approach consisting of multiple
surgeries at different stages.
We work together with the child and the family to provide the
best possible outcomes and improve the child's quality of
life.
Smile Makeover
A good smile contributes immensely towards a good
personality. Smile designing is truly a work of art. The
term smile design applies to the enhancement of a smile
using a combination of methods.
We can enhance each and every smile with latest
technology in cosmetic dentistry. For a
Perfect aesthetic outcome proper planning and
combination of one or more treatments are needed.
CIMS State-of-the Art Dental area:
• Minimum Dental Sittings
• Less Operational time
• Painless Treatment
No Cross Infection
• Day care/indoor facilities for medically compromised
and seriously ill patients
• Facility of general anaesthesia on dental chair only
• Total care for NRI and overseas patients by special
international patient's department
75
Pathology
The Pathology Department at CIMS is NABL accredited clinical laboratory well-equipped to carry out the latest test on
patients sample and assist clinicians in evaluation and diagnosis of diseases.
Aided by state of the art fully automated instruments & highly skilled HPC registered biomedical scientists under constant
supervision of consultant pathologist with a high quality assurance. CIMS Pathology provides near-perfect pathology
services to all patients.
The Pathology Department provides a range of services including:
76
Pathology
77
Pathology
Markers for Infectious Diseases
78
Pathology
79
Radiology
The department is equipped with technologically advanced,
state-of-the-art medical equipment in our endeavor to
provide the best diagnostic output. The department consists
of highly skilled radiologists and technicians who are
dedicated to provide 24X7 patients care. The department is
also actively involved in pushing boundaries in the world of
radiology and imaging through various research activities.
Department of Radiology and Imaging at CIMS
hospital offers services of :
Diagnostic Imaging Modalities
• Plain Radiography
• Fluoroscopy
• Ultrasonography and Color Doppler
• Mammography
• Computed Tomography
• Magnetic Resonance Imaging
• Interventional Radiology
Total Numbers
Physiotherapy team handles patients of CABG, Valve
Replacement, PTCA, Congenital heart diseases etc. at pre and
post procedure.
A. Orthopedic patients with Total Knee Replacement, Hip
Replacement, Amputation and Post trauma are treated effectively
so as to bring them back to normal life and make patient
independent of all the daily living activities.
B Neurological interventions of Road Traffic accidents,
Ventilator-dependent , Comatose patients etc. are treated
effectively by giving Chest Physiotherapy, Limb Physiotherapy,
Mobilization support, Locomotor-gait training and more to
improve their activities of daily living.
C. WOMEN WELLNESS PROGRAMS : CIMS, provides total
women fitness program that includes obesity management, pre-
natal and post natal (before and after pregnancy) exercises
and post-menopausal rehabilitation.
D. GERIATRICS REHABILITATION (ABOVE 60 YEARS OF
AGE): Geriatric Physiotherapy uses a wide range of skills to
accommodate the unique issues of aging,
Which include multiple medical diagnosis, mobility and balance
impairments and challenges of independent living.
AT CIMS, Physiotherapy team renders quality supportive
services to improve patient care.
CIMS Physiotherapy & Rehabilitation Centre is equipped with
latest equipment’s to give high standard of services. CIMS
treat individuals for all illness which includes heart, lungs,
back, neck, shoulders, elbows, knees, hands, etc. CIMS
provides multidisciplinary
Integrated quality care to patients.
At CIMS Rehabilitation Services Include:
• Cardiac Rehabilitation
• Orthopedic/musculoskeletal Rehabilitation
• Neurological Rehabilitation
• Pulmonary Rehabilitation
• Post-Surgery Rehabilitation (including liver and k i d n e y
transplant)
• Pain management
• Nutritional Counseling
• Yoga Sessions
• Manual Therapy and Electro Therapy
80
Physiotherapy
81
Code Blue
Code blue is an emergency situation announced in a
hospital or institution wherein a patient is in
cardiopulmonary arrest or respiratory arrest requiring a
team of personnel to rush to the specific location and
begin immediate resuscitative efforts.
CIMS hospital has rapid response team or “blue code
team” to reduce preventable in-hospital deaths.
is generally used to indicate a patient
requiring resuscitation or otherwise in need of immediate
medical attention, most often as the result of a
respiratory or cardiac arrest.
A single telephone number '222' is used for all Code
Blue events at CIMS. The call will automatically be
directed to the Emergency Department who will dispatch a
Code Blue Response Team.
Calling criteria for our Blue code service are based
on acute changes in
Ÿ Heart rate (<40 or >130 beats/min),
Ÿ Systolic blood pressure (<90 mmHg),
Ÿ Respiratory rate (<8 or >30 breaths/min),
Ÿ Conscious state, urine output (<50 ml over 4 hours),
and Oxygen saturation derived from pulse oximetry
(<90%, despite oxygen administration).
“Blue Code”
82
Quality Measures
As a part of mission it has remained the prime motto of CIMS
hospital to provide quality care to its patients.
Careful efforts are undertaken by the hospital
management to minimize infection and impart high
quality standards to patients.
Consequently, performance measurement and reporting
has become ingrained in our system by establishing
Quality Assurance Department. The ultimate goal of it is
to improve care and outcome.
Hospital-acquired infection rates at CIMS are very low.
Typically, the two leading causes of hospital-acquired
infections in the ICU are central line infections and
ventilator-associated Events (VAE). A mindset of zero
infection tolerance at CIMS and the consistent following
of protocols have resulted in reduction in central line
infections over past years. This reduction in catheter-
related bloodstream infections has saved many lives
and significantly reduced health care costs. Similar
results have been achieved in lowering the rate of VAE
and in reducing blood transfusions.
Ambulance and Transport Services
83
The department is geared to face challenges of
the Pediatrics age groups with in-house Pediatrics /
Neonatology Care.
Our Road Ambulance Services has two levels of medical
transportation
Basic Life Support (BLS)
These road ambulances are best suited for...
ŸNon-emergency patient transport
ŸTransport to any other medical diagnostic appointment
ŸHospital Discharges
Advance Cardiac Life Support (ACLS)
These road ambulances are recommended for
transporting...
ŸCardiac Emergencies: Acute Myocardial areas of dead
tissue, precarious Angina and generally stable
cardiovascular patients from one hospital to the other for
procedural help/better care to higher centers.
ŸCritically ill Patient: These patients are usually on
ventilator supported, septicemia shock with multi organ
failure and on various life support equipment. These kind
of patients require bed to build transportation without
removing running prescription and medical equipment.
These types of transportation done by ACLS ambulance, in
which we provide all ICU backups with one doctor (ICU
specialist) and one trained technician. This can be with the
city ICU's or from one city to the other city in India.
CIMS Hospital has a well organized strategically placed fleet
of ambulances in order to serve the increasing emergency
medical needs.
They are provided with high quality communication
systems enabling them to contact base unit and other
places effectively maintaining high quality standards
and efficiency in all its services.
Round the clock ambulance service is available which
is equipped with a mobile ICU- set-up to transport
critical patients.
Other state pick up and drop services include states of
Rajasthan, Madhya Pradesh and Maharashtra.
Ambulance Number of Services
Patient Drop 290
Patient Pick up 277
Other 43
84
Care At Homes
Care at homes is a pioneer service of CIMS in bringing
personalized and professional home health care services to
allow quick and convenient recovery within the comfort of
one’s home. Some of the key medical services offered
include setting up ICU at home, providing Cancer Care at
homes, nursing care, physiotherapy services and holistic
stroke rehabilitation along with providing plethora of clinical
procedures at home thereby delivering almost 70% of all
clinical services at home.
A level of services which emphasizes on a high level
of cleanliness and hygiene from our staff to meet and
exceed the healthcare industry's highest standards.
Ÿ24-our services, including all holidays and weekends
ŸHighly trained and experienced healthcare professionals
ŸRegular assessments by managements to ensure
client satisfaction
ŸAt homes consultation
Our Services
ŸImplementing clinical care planes
ŸAttending to disabilities, chronic illness, and/or
therapies
ŸCoordinating home medical equipment, pharmacy and
supplies
ŸPharmacy (medications) at patient's doorstep
ŸPerforming personal care
ŸAssisting with daily activities
24 x 7 Specialized Nursing Services
ŸEscort for patients shifting
ŸWound care and dressing
85
Care At Homes
ŸIntravenous (IV) infusion therapy, intra Muscular (IM)
and Sub Cutaneous (SC) injections
ŸFocus on continuous training and development
ŸCatheter (urinary) insertion and care
ŸVaccination in home
Caregiver Services
ŸBathing, grooming and toiletry services
ŸEscorting patients for appointment
ŸMobilization and ambulation with walker and wheel
chair
ŸNutrition assistance with eating
ŸPicking up prescription and medication reminder
Rehabilitation Services
ŸPhysiotherapy (Occupational Therapy & Rehabilitation
center)
ŸNutritional assessment (with qualified Dietician)
CIMS Hospital has achieved Joint Commission International
(USA) accreditation and earned Gold Seal of Approval in
Quality and Patient Safety Assisting with mobility and
transfers.
CIMS has provides 289 nursing staff services, 385care giver
staff services, 36 doctor visit services, 15 physiotherapy
services, 35 medical bed services, 55 oxygen cylinder
services, 9 nebulizer machine services, 8 air bed services,
10 infusion pump services, 20 suction machine, 20 wheel
chair,12 I.V stand, 4 ventilator/bipep services, 8 ECG
services, 14 home sleep study in this year.
A U N I T O F C I M S H O S P I T A L P V T L T D
86
Patient’s Say
N.S : We were lucky that we reached CIMS for angioplasty. We are completely satisfied with doctors, staff and overall
facilities for hospital. Recommend for your family and friends.
M.P: I have come across the best doctor of the Gastro- Intestinal Physician in Ahmedabad City -Dr.Bhavesh Thakkar (Gold
Medalist, Gastro-Intestinal Physician) at CIMS Hospital. He is too good in checkups & diagnostics of the disease & its
cause. He treated my elder sister of age 76, with correct medicines & recommended permanent solution by doing
operations for long life cure for rest of her Life. Her operation was successfully done by Dr.Manish Gandhi (Surgeon
Gastroentrology ) of CIMS hospital.
I am very grateful to both of them. He is best Gastrointestinal Surgeon.
I would highly recommend both & their teams , to Everyone or any One Suffering from Gastrointestinal problems , CIMS
Hospital is The Best Hospital in Ahemdabad with along with the All other Good Doctors & Supporting Doctors , Nurses & All
Staff.
P.G: I have been going to CIMS hospital since 2011 and am really impressed with the facilities created for care of the
patient. Moreover,the staff is trained and courteous and gives full attention to patient's requirements.I wish the hospital a
bright future
R.T: Today CIMS representative Visited Our Home Daman from Ahmedabad so Far to See my Father. It's great Feeling and
... Gave Guidelines ... Really it's a Great Step of Hospital after Discharge to come and visit Patient at Home which no
Hospital Does.. Hope Very Best .. Great Success for Hospital to Serve for Humanity..
It proves that they Not Only take care at Hospital where you don't feel like Hospital, they Take Care at Our Home Also..
Thanks Dr KEYUR PAREKH, Dr Ajay Naik and Dr Rupesh Shah and all management for Full Cooperation and taking care
of my Dad.
B.B: Patient care is best. Cleaning and infrastructure is very good. Nice and proper care given from lower level staff to
higher level staff. Post services are also good. Best response given by all. PGET is very friendly and good.
N.G: Best cancer surgen and Like an angel of god
Thanks Dr. Tarang sir and Dr.Rahul Jaiswal
Because my daughter had ovary cancer dysgerminoma, which was surgically removed by doctor Tarang Patel, and then
the cancer was spread and prevented by chemotherapy by Dr. Rahul Sir
87
Ethics
ŸEthics Committee of Care Institute of Medical Sciences
was initially registered by Central Drugs Standard Control
Organization, Government of India with Registration
number ECR/206/Inst/GJ/2013 and re-registered with
ECR/206/Inst/GJ/2013/RR-16 as per the provision of Rule
122DD of the Drugs and Cosmetics Rules, 1945
ŸEthics Committee of Care Institute of Medical Sciences is
accredited by National Accreditation Board for Hospitals &
Health care Providers (NABH), Constituent Board of
Quality Council of India (QCI) under clinical trial program
with certificate number EC-CT-2017-0001 accreditation till
August 05, 2020 also EC NABH surveillance assessment
was done on 21st & 22nd December 2018.
The underlying goals of CIMS ethics committee are:
ŸTo promote the rights of patients;
ŸTo promote decision making between patients and their
clinicians;
ŸTo promote fair policies and procedures that maximize the
likelihood of achieving good, patient-centered outcomes.
ŸTo enhance the ethical environment for health care
professionals in health care institutions.
Code of ethics
ŸThe management is fully aware of ethical management
and ethical practices. Hospital has established the CIMS
Ethics Committee. Committee follows code of ethics
established by Medical Council of India, Indian Council of
Medical Research (ICMR) and ICH-GCP guide lines.
Scope of committee
ŸReview and approve clinical trials/studies (drugs and
devices) both observational, academic, Investigator
Initiated.
88
Research Projects
CIMS Research Center, which has been participating in the
Clinical trials since more than a decade and having
experience of more than 120 trials (phase III, phase lV,
registries and device). CIMS Research center is well
established department which offers suitable infrastructure
as per the clinical industry norms, highly experienced team
of Doctors and full time clinical research coordinators
dedicated to conduct the clinical trials flawlessly.
We are having experience of conducting clinical trials in
various therapeutic areas like Cardiology, Pulmonology,
Oncology, Orthopedics, and Gastroenterology.
1) Evaluation of A New Scatter Radiation Reduction and
Ergonomic Support System in A High-Volume,
Percutaneous Coronary Diagnosis and Intervention
Laboratory
Background: The Cardiovascular TransRadialAccess
Platform (Cardio-TRAP®) is a radiation protection
technology with ergonomic modular design to absorb more
than 95% of incident radiation during right transradial
percutaneous coronary intervention (PCI).It offers scatter
radiation protection for the physician and scrub nurse in their
most neglected zones (arms, face, and head).
Method: Observational, randomized, prospective, single
center comparative study was conducted at CIMS.
Operators were randomly divided into shield and non-shield
groups and radiation doses at the four body sites (wrists,
right collar and forehead) were recorded by electronic
dosimeters (IPD-1301) during right transradial PCI.
Results: A total of 51consecutive subjects underwent radial
PCI amongst them 25 subjects were assigned in shield
group and 26 subjects were in non-shield group. Both the
groups were well matched with respect to body mass index
(BMI).Procedural table height averaged to 93.4 ± 0.62 cm.
Conclusion: The Cardio-TRAP® is a simple but novel
technology and its results demonstrate there was a
significant radiation dose reduction to the both operator’s
physician and technician for right radial-access PCI support.
Research Projects
89
2) Transradial Left Main Coronary Artery Stenting
Procedural and Long Term Clinical Outcomes
Background: Transradial (TR) approach is a fast growing
alternative to the routine use of Trans Femoral (TF)
approach in percutaneous coronary interventions (PCI). Aim
of the study was to compare long-term clinical outcomes of
TR and TF PCI in patients with left main coronary artery
(LMCA) bifurcation lesions with respect to procedural and
clinical outcomes.
Method: Between August 2010 to August 2019, 198
patients with LMCA stenosis ≥ 50% underwent PCI at a
group cardiology practice center. 166 patients underwent
TR while 32 underwent TF intervention. The primary
endpoint was composite of all-cause mortality, MI or stroke.
Resul ts : Bo th g roups had s im i la r base l ine
characteristics(propensity score<1) with 100% procedural
success with right radial artery using 5F/6F sheath.
Procedural time was less in TR group as compared to TF
group (46.92 and 83.41 mm:ss; p<0.0001, 36.49%
difference; 95% CI [21.87 to 51.10]). Fluoro time and
contrast volume were less in TR group as compared to TF
group (17.17 and 25.48 mm:ss, p= 0.0023, 95% confidence
interval, 3.0209 to 13.5991) while fluoro dose was higher in
TR group as compared to TF group. At 9 years, with median
follow-up of 4 years -of the 4 MACE in TR intervention, 3
underwent CABG, while 1 was hospitalized for
cerebrovascular stroke. In the TF group, one patient
underwent CABG. Patient wellness was better in TR group
as compared to TF group.
Conclusion:TR-PCI is a safe, effective, less time
consuming, more patient compliant as compared to TF
vascular approach, even in patients with LMCA bifurcation
lesions undergoing PCI.
Table 1. Long-term follow-up data
Image 1: Kaplan Meier Survival Analysis
Research Projects
Research Projects
90
3) Safety and efficacy of Sirolimus coated balloon with
Nanolute technology in real-world coronary artery
disease patients: Angiographic and clinical outcomes
Background and aim: Drug coated balloon has emerged
as a new treatment modality for coronary artery disease
specifically in patients with complexity such as in-stent
restenosis, small vessel and bifurcation stenosis. We aim to
evaluate safety and efficacy of MagicTouch Sirolimus
coated balloon for the treatment of both de-novo and in-stent
restenotic coronary lesions.
Methods: A prospective, single-arm, single center, real-
world study which included 131 all-comer patients who
underwent sirolimus coated balloon angioplasty was
conducted. The study endpoint comprised of major adverse
cardiac event (MACE) at 6-months and 1-year. The
components of MACE were target lesion/vessel
revascularization (TLR/TVR), target vessel myocardial
infarction (TV-MI) and cardiac death. Quantitative coronary
angiography (QCA) was performed and post procedural
outcomes are presented. Reference vessel diameter
(RVD), minimal lumen diameter (MLD), and % diameter
stenosis (DS) were measured at baseline and post-
procedure.
Results: Mean age of the 131 enrolled patients enrolled
was 60.1 ± 10.1 years with male predominance (83.2%);
encompassing 139 lesions treated by sirolimus coated
balloon. Diabetes mellitus was present in 31.3% patients
while 40.5 % patients were hypertensive. Half of the patients
presented with acute coronary syndrome (50.4%).
Amongst the 139 treated lesions, 77 % lesions were de-
novo while 23% were in-stent restenotic lesions. SCB alone
treatment strategy was employed in majority of the patients
(91.6%) while additional treatment was required in 8.4% of
patients. The mean sirolimus coated balloon size and length
were 2.57 ± 0.49 mm and 25.2 ± 7.2 mm respectively.
Procedural success was 100% with no flow-limiting
dissection reported. Angiographic outcomes were available
for 112 patients with 128 lesions. MLDs were reported as
0.39 ± 0.30 mm and 1.57 ± 0.55 mm pre-procedure and post
procedure respectively. The results depict increased lumen
diameter and acute gain post procedure. Increased lumen
diameter post procedure with acute gain of 1.18 depicts that
SCB is associated with good immediate outcomes with well
flowing coronaries after the treatment. At 1-year, all patients
completed clinical follow-up and the incidence of MACE was
reported as 3.8%. MACE rate was mainly driven by
TLR/TVR (3.1%) followed by cardiac death (0.8%). There
was not TV-MI reported at 1-year.
Conclusion: In real-world, high-risk patients with complex
coronary artery lesions, MagicTouch Sirolimus coated
balloon is a safe and efficacious treatment strategy as
evidenced by angiographic assessment and clinical
outcomes.
91
Research Projects
4) Comparative Safety and Efficacy of Mechanical and
Biological Prosthetic Valves: A Heart Valve Centre
Findings
Objective: The goal of this study is to compare the
efficacy and safety between different mechanical and
biological valves after valve replacement surgery at a heart
valve centre
Background: Both mechanical and biological valves are
prosthetic valves deployed as valve replacement
management. The major concerns when implanting heart
valve prosthesis are primary tissue failure after implantation
and hemodynamic performance. Both types have been
shown to warrant satisfactory hemodynamic results and
tissue durability over 10 to 15 years. As per literature
Biological valves may be specifically suited to the Indian
scenario. Hence, in India the ideal substitute for heart
valve is still a debatable issue. The present study places
real world data of a heart valve centre.
Method: We carried out single centric, retrospective study
involving patients with valve replacement surgery..
Primary end points of the study were pre and post-
operative echo parameters like LVEF (left ventricular
ejection fraction), LVFS (left ventricular fractional
shortening), LVD Diastolic, LVD Systolic, EPSS (E-Point
septal separation). Also pre and post-operative Blood
Pressure, Heart Rate, Respiratory Rate, Pre and post-
operative INR (International Normalized Ratio),
electrolytes, serum creatinine were studied. Secondary end
points of the study included adverse events or
complication like difficulty in breathing, bleeding, chest
pain, weakness, arrhythmia and death.
Results: A total of 290 patients were analyzed, of which 144
were implanted with mechanical valve while 146 with
bioprosthetic valve. There were no overall differences in
echo parameters, baseline parameters and electrolytes
parameters between biological and mechanical valves.
Valve related complications like bleeding, chest pain
and arrhythmia occured more frequently in patients with
mechanical prosthesis than in those with a bioprosthesis.
There were 6 death reported in mechanical valve group
and 3 death in biological group. In our study we also
found that patients with either mechanical or biological
valve implantation had similar improvement in mitral
position but patients undergoing aortic valve
replacement with mechanical valve had better
improvement than bioprosthetic valve. Estimated 10-year
survival free from valve-related morbidity was better for the
mechanical valve in patients aged less than 65 years and
was better for the biological valve in patients aged more than
65 years.
Conclusion: More than 20 years after the introduction of
modern prostheses, the choice of biologic versus
mechanical aortic valve prostheses remains difficult.
92
Research Projects
5) To Analyze Prognostic Implications of Coronary
Artery Bypass Timing after Myocardial Infarction and to
Determine the Contributing Pre-, Peri- and Post
Treatment Variables
Objectives: The optimal timing of coronary artery bypass
grafting (CABG) after myocardial infarction (MI) is still
controversial. With advances in perioperative care and
myocardial protection, CABG is not infrequently
undertaken sooner. Although CABG soon after MI is
associated with high morbidity and mortality. Such a
wide variation has created a dilemma in the
management of these patients. The objective of the study
was to delineate the optimal timing of revascularization
after acute myocardial infraction in large and
contemporary patient population.
Methods: We analyzed ambispectively data of 500
patients who underwent primary CABG. Operative
outcomes of patient categories based on MI- to- CABG
days: groups A (0–7, n = 212), B (7- 30, n = 77), C (>30, n =
11) and D (no MI, n = 200). The effect of the timing of
surgery on survival was determined using multivariate
analyses.
Results: As the MI- to- CABG interval increased, hospital
mortality (A, 3.77 % vs. B, 2.59% vs. C, 0%, vs. D, 4%, P <
0.0001) steadily declined. In general, patients who had
CABG within 30 days of MI had more cardiac morbidity
and comorbidities. Expectedly, therefore, postoperative
organ system dysfunction (cardiac, renal, respiratory and
neurological) was more frequent in these groups.
Reoperation for bleeding was similar for all groups , but
blood product transfusion decreased as the MI- to- CABG
days increased. By multivariate analysis, the MI to- CABG
interval was not a risk factor for operative or late mortality.
However, less frequent left internal mammary artery use,
non - elective surgery and high blood transfusion rates were
all more often associated with shorter MI- to- CABG
intervals.
Conclusions: Mortality risk for CABG declines with
increasing intervals from MI for reasons indirectly linked to
the timing of surgery. Our findings emphasize the
importance of preoperative organ system optimization and
consistent left internal mammary artery use, regardless
of the proximity of surgery to MI or the exigency of
surgery.
6) Prevalence and Outcome of Atrial Fibrillation in
Coronary Artery Bypass Graft Patients as a Function of
Creatinine Clearance: A Prospective Study
Background: Postoperative atrial fibrillation (POAF) occurs
in 15% to 30% of patients who undergo CABG. Pre, peri-
and post-operative variables influence prevalence and
outcome of POAF. Objective of the present study was to
determine the influence of renal dysfunction on prevalence
of POAF and early post-operative mortality in CABG
patients.
93
Research Projects
Method: A prospective study was conducted at a tertiary
care hospital on patients undergoing CABG. Glomerular
filtration rate (eGFR) was estimated using the Modification
of Diet in Renal Disease equation and Creatinine clearance
(eCcr) was estimated using Cockcroft-Gault formula.
Patient with Glomerular filtration rate <60 ml/min/1.73 m2
and Creatinine clearance < 80 mL/min related renal
dysfunction.
Result: A total of 500 patients underwent CABG; Off pump
89.2%(Table 1). Renal dysfunction was concluded in 217
(43.4%) patients on the basis of eCrc and eGFR. Incidence
of atrial fibrillation as determined by prolonged P wave
duration post CABG occurred in 93(18.6%) cases, more so
(45.16%) on the second day post CABG. Renal dysfunction
was present in 58(62.4%) of total POAF cases. ACEI/ARB’s
did not contribute to development of renal dysfunction. All
the 24(4.8%) cases of early post-operative death at 6
months had associated renal dysfunction; 13(54.2%)of
which had POAF also.
Table 1: Baseline characteristics
Conclusion: Impaired creatinine clearance independently
increases the risk of early death after CABG besides
contributing to prevalence of POAF.
7) Early Follow–up and Continuous Surveillance Post Coronary Artery Bypass Graft Surgery-A Hospital to Home Health Care Initiative.
Background: CABG infections are serious in terms of human and financial cost more so in diabetic and obese subjects. Objective of the Hospital to Home (H2H) follow up visit, a first of its kind program was initiated to identify adverse cardiac events, improve glycemic control, reduce readmissions, improve patient survival, and enhance quality of care with lower health care expenditure for CABG patients.
Methods: A total of 2507 CABG at a tertiary care hospital in Western India were studied. Trained healthcare personnel initiated H2H visits on 809(32.26%) patients following discharge after CABG surgery.
Results: At 5 days post discharge early follow up H2H visits depicted medical complications (236(29.17%)) like wound infection (5.97%); poor dressing conditions (3.98%); inappropriate chest belts (6.80%) and poor hygiene (2.22%) besides chest pain, palpitation and breathlessness . Adverse drug reactions were reported in 34 patients of whom 18 were resolved at visit. Drug adherence was observed in 485 (60%) patients. 18(2.22%) patients had ordered lab tests, which they had not completed.98 patients were advised to see their routine physician for diabetes control following glucose test. Majority of patients (89%) revealed a satisfaction score> 8/10. Quality of Life was excellent in 29.17%; very good in 20.02%; good in 11.74% and fair in 1.24% patients. At 30 days 1.12% readmissions occurred. H2H visits reduced readmission by 15% and complications by 8 % as compared to non H2H data.
Conclus ion: Dur ing H2H v is i t s appropr ia te treatment/counseling given to patients and their family members reduces healthcare costs by reducing complications; improving medication compliance, patient satisfaction and rehabilitation, promoting self- care and activation.
CIMS Foundation
94
ŸGrant of subscriptions and donations to deserving
private and public institutions for administering
medical relief to the needy people.
ŸTo interact with patients and relatives on daily basis to
collect and maintain patient data required for philanthropy.
ŸTo collect donations from donors for contribution and
disburse the donation to under privileged patient.
ŸThe Smallest of your contribution will make the biggest
of difference. To a Life , To a Family , To Faith, To
Survival, To Happiness.
ŸYou can send your donation by cheque/ DD in favour of
“CIMS Foundation” payable at Ahmedabad or transfer
direct to our bank account.
Our Corporate Partners
1) Areez Khambatta Benevolent Trust
2) Reeta Keyur Parikh Charitable Trust
3) Palash Patel Foundation
4) INTAS Pharmaceuticals Ltd.
5) Vikram Advisory Pvt. Ltd
6) Astral Poly Technik Limited
7) Sequel Logistics Pvt. Ltd.
8) Lonsen Kiri Chemical Industries Ltd.
Our Institutional Partners
ŸIIM Ahmedabad
ŸGujarat Vidhyapith
CIMS Foundation is combination of financial and social
activities: We organize camps and lectures to create
awareness across the cross section of the societies,
schools & colleges. More than 10000 people took
advantage of this initiative of CIMS Foundation
CIMS Foundation (Regd. No. E19607) is a registered
trust under Income Tax Act 19614, subject to the limits
prescribes therein and certified that donation made to the
trust shall qualify for deduction u/s 80G(5) of the Income Tax
Act, subject to the limits prescribed therein.
CIMS Foundation Focus Areas
ŸTo support patients and the family members who are
socially , emotionally and financially weak.
ŸTo assist people who cannot complete their medical
treatment/care due to financial constraints.
ŸTo establish regular camps for providing medical
assistance at doorsteps in the rural areas.
ŸTo promote the welfare of children in need,
including children with physical disabilities and/or life
threatening diseases.
ŸTo provide care, hope and dignity to all patients to fight
against the disease and maintain good quality of life.
-Mahatma Gandhi”
“
Name : IDBI Bank
A/C No. : 0067102000026798
IFS Code : IBKL0000067
Branch : Bodakdev, Ahmedabad
Name : HDFC Bank
A/C No. : 50100354412195
IFS Code : HDFC0001229
BANK DETAILS :
Your smallest contribution can make an immense difference
CIMS Learning Center
95
Care Institute of Medical Sciences (CIMS) is pleased to
present “CIMS Learning Center (CLC)” Program for the
year 2019.
Growth is driven by curiosity; curiosity is assuaged by
knowledge. And knowledge is gained by continuing
education.
At CIMS CLC, we recognize that teaching and practice go
hand in hand. CLC is founded on that premise. To share
what we learn and pursue bigger ideas.
From the last 21 years, we have been holding a continuous
stream of workshops, CMEs, Fellowships and Annual
conference JIC (hosting more than 2000 delegates) to
uphold our academic endeavors.
CIMS Learning Center Program offers continuing
medical education opportunities for a variety of faculty
and medical providers, including Physicians,
Technologists, Researchers and Nurses.
We do provide best medical facilities to our patients;
but we also are driven by the need to learn and
teach.. to create a vast body of professionals highly
committed to the pursuit of world-class healthcare with
knowledge at their fingertips.
CIMS LEARNING CENTREAn Academic Initiative of CIMS Hospital
Paramedical Training for Dynamic Aspirants
*In collaboration with Ahmedabad Institute of Medical Science(AIMS),
Affiliated to Gujarat University & recognized by Government of Gujarat (Few Courses Only)
Certificate Courses
Eligibility : 12th Pass (Any stream)
Eligibility : Graduate in Any Stream
Eligibility : Graduate in Science Stream
Eligibility : GNM/B.Sc in Nursing
Eligibility : Medical & Para Medical Graduates
CIMS Education
96
As a continuous process of education and social
awareness, CIMS has organized more than 22 CMEs at
various places of Gujarat, Rajasthan and MP.
CIMS hospital also conducts in-house learning courses
like Echo fellowship, ECG Learning (Basic and Advance)
and, CPR training for medical fraternity as well as
common man.
CIMS also organizes various national and international
conferences like JIC, NATACON, AFPACON, NGPCON,
APGCON etc.
CIMS Health care
Awareness
Programme Venue
Number of
Participants
Ahmedabad
Balotra
Barmer
Bharuch
Bhavnagar
Bhilwara
Bhuj
Chittorgarh
Deesa
Idar
Jamnagar
Kadi
Kasindra
Khambhat
Kheralu
CIMS Health care
Awareness
Programme Venue
Number of
Participants
Mehsana
Mewada
Morbi
Neemuch
Palanpur
Pali
Patan
Rajkot
Ratlam
Runi (Thara)
Sanchore
Sumerpur-Seoganj
Surendranagar
13867
35
420
25
180
68
732
60
41
43
46
275
170
150
14
140
157
42
480
53
960
23
199
12
825
35
22
36
Publication List (Last 6 Years)
97
1. Parloop Bhatt, Vipul Kapoor, Milan Chag, Satya Gupta, Anish Chandarana, Parth Parikh, Apurva Patel, Roosha Parikh,
Hemang Baxi, Urmil Shah, Aditi Nanavati, Piyush Thakar, Tejas Patel, Keyur Parikh Evaluation of A New Scatter Radiation
Reduction And Ergonomic Support System In A High-Volume, Percutaneous Coronary Diagnosis And Intervention Laboratory
(Abstract Accepted in American College of Cardiology ACC March -2020)
2. Keyur Parikh, Parloop Bhatt, Milan Chag, Hemang Baxi, Urmil Shah and Tejas Patel Safety and efficacy of Sirolimus coated
balloon with Nanolute technology in real-world coronary artery disease patients: Angiographic and clinical outcomes (Abstract
Accepted in EuroPCR 2020)
3. Keyur Parikh Clinical efficacy and safety of Sirolimus coated balloon in a real world single center registry of Indian population
(Abstract Accepted in EuroPCR 2020 India live 2020)
4. Parth Parikh, Parloop Bhatt, Deepa Shah, Piyush Thakar, Ajay Naik, Hemang Baxi, Shmuel Banai, Keyur Parikh First-in-
Human Use of Coronary Sinus Reducer in Patients With Refractory Angina Journal of the American College of Cardiology
December 18, 2018, 72 (24) 3227-3228; DOI:10.1016/j.jacc.2018.09.061
5. Parth Parikh, Parloop Bhatt, Deepa Shah, Piyush Thakar, Ajay Naik, Hemang Baxi, Shmuel Banai, Keyur Parikh, "First-in-
Human Use of Coronary Sinus Reducer in Refractory Angina: 12 Years Anatomical and Clinical Outcomes" (Manuscript Accepted
at JACC 2018)
6. Parloop Bhatt, Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet
Sankhla, Tejas Patel, Vipul Kapoor, Piyush Thakar, Aditi Nanavati, Keyur Parikh NCDR® as a Resource Improvement in Hospital
Quality Parameters Abstract Accepted at NCDR 2018
7. Parloop Bhatt, Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet
Sankhla, Tejas Patel, Vipul Kapoor, Piyush Thakar, Aditi Nanavati, and Keyur Parikh Achieving Highest Benchmarks in
Interventional Cardiology: NCDR® Cath PCI a Critical Contributing Factor Abstract Accepted at NCDR 2018.
8. Parloop Bhatt, Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet
Sankhla, Tejas Patel, Vipul Kapoor, Piyush Thakar, Aditi Nanavati, Keyur Parikh Reduced Median Fluoro Time: An Outcome of
NCDR® Participation Abstract Accepted at NCDR 2018
98
9. Parloop Bhatt, Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet
Sankhla, Tejas Patel, Vipul Kapoor, Piyush Thakar, Aditi Nanavati, Keyur Parikh Reduced Percutaneous Coronary Intervention In-
hospital Risk Adjusted Rate of Mortality And Bleeding Events via Radial Access: NCDR® Findings Abstract Accepted at NCDR
2018
10. Keyur H. Parikh, Sameer Dani, Ranjan Shetty, Prathap Kumar, J.S.Hiremath, Dinesh Shah : Sirolimus Coated Balloon For the
Treatment of Coronary Artery Stenosis: Long Term Outcome From a Real World Experience (Abstract Accepted in American
College of Cardiology ACC March -2018)
11. Keyur H. Parikh, Sameer Dani, Ranjan Shetty, Prathap Kumar, J.S.Hiremath, Dinesh Shah : Treatment of Coronary In-Stent
Restenosis With Sirolimus Coated Balloon Catheter: Sub-Analysis Results From Nanolute Study (Abstract Accepted in American
College of Cardiology ACC March -2018)
12. Keyur H. Parikh, Clinical efficacy and safety of Sirolimus coated balloon in a real world single Center registry of Indian
population
13. Parloop Bhatt, Parth Parikh, Anish Chandarana, Milan Chag, Vipul Kapoor, Aditi Nanavati, Tejas Patel, Satya Gupta, Hemang
Baxi, Urmil Shah, Vineet Sankhla, Neil Jain, Keyur Parikh, CIMS Hospital, Ahmedabad, India, L. M. College of Pharmacy,
Ahmedabad, India: Impact of Drug Eluting Stent Price Reduction in India: Selection for Stent Type Placement and Associated
Outcomes.
14. Keyur H. Parikh, Parth Parikh, Parloop Bhatt, Aenasha Chag, Hemang Baxi, Milan Chag, Urmil Shah, Satya Gupta, Anish
Chandarana, Manish Doshi, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: Real World
Clinical Outcomes of Sirolimus Coated Balloon in Coronary Artery Lesions: Results from Single Center Study.
15. Keyur H. Parikh, Parth Parikh, Deepa Shah, Parloop Bhatt, Piyush Thakar, Ajay Naik, Hemang Baxi, Shmuel Banai, CIMS
Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: Coronary Sinus ReducerTM Retains Patency and
Efficacy at Twelve Years: A Prospective Cardiac CT Angiography Outcomes.
16. Patel B Krunal, Chag C Milan, Gupta B Satya, Bhatt A Parloop, Parikh K Parth, Patel Aditi, Patel K Apurva, Jain N Neil, Parikh H
Keyur, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: First In Man Vascular Use Of
Axiostat®: A Novel Whole Chitosan Haemostatic Dressing For Transradial Coronary Intervention Accepted: At WEC, Rajasthan,
India, October, 2017
Publication List (Last 6 Years)
99
17. Dhiren Shah, Milan Chag, Deepa Shah, Dhaval Naik, Amit Chandan, Chintan Sheth, Niren Bhavsar, Hiren Dholakiya, Parloop
Bhatt Late Coronary Stent Infection: A Difficult to Diagnose Rare Complication after Percutaneous Coronary Intervention
Manuscript Accepted at Indian Journal of Thoracic and Cardiovascular Surgery (IJTC-D-18-00066R1) 2018
18. Parikh K Parth, Patel B Krunal, Chag C Milan, Gupta B Satya, Bhatt A Parloop, Parikh K Parth, Patel Aditi , Patel K Apurva, Jain
N Neil, Parikh H Keyur, CIMS Hospital, Ahmedabad, India, Cleveland Clinic Foundation, Cleveland, OH, USA: Superiority Of
Newer Oral P2y12 Inhibitors In Treatment In Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention At
A High Volume Non-Us Center Abstract Accepted: at WEC, Rajasthan, India, October, 2017
19. Keyur H. Parikh, Parth Parikh, Parloop Bhatt, Satya Gupta, Hemang Baxi, Urmil Shah, Tejas Patel, Milan Chag, Sameer Dani,
Ranjan Shetty, Prathap Kumar, Jagdish Hiremath, Dinesh Shah, Manish Doshi, CIMS Hospital, Ahmedabad, India, Cleveland
Clinic Foundation, Cleveland Clinic, India: Prospective Real World Registry for the Use of Sirolimus Coated Balloon in Small Vessel
De Novo Lesions (Accepted in American College of Cardiology ACC March -2018)
20. Parth Parikh, Parloop Bhatt, Vipul Kapoor, Hemang Baxi , Satya Gupta, Tejas Patel, Anish Chandarana, Roosha Parikh,
Apurva Patel, Keyur Parikh. Optimal P2Y12 Inhibitors for Primary Percutaneous Coronary Intervention Patients in ST
Segment Elevation Myocardial Infarction: Actual Care Trends and Outcomes. Accepted and presented in SCAI 2017,
Orlando.
21. Parth Parikh, Apurva Patel, Parloop Bhatt, Milan Chag, Roosha Parikh, Anish Chandarana, HemangBaxi, Satya Gupta, Vipul
Kapoor, Vineet Sankhla, Keyur Parikh, Care Institute Medical Sciences, Ahmedabad, India, Cleveland Clinic Foundation,
Cleveland, OH, USA: Evaluation of a New Radiation Protection Technology (Cardio-TRAP®) in Transradial Percutaneous
Coronary Intervention Procedures. Abstract Accepted and presented at ACC 2017,Washington, DC. Published in Journal of
the American College of Cardiology 69(11):1365 · March 2017. DOI: 10.1016/S0735-1097(17)34754-X.
22. Poonam Chodvadiya, Keyur Parikh, Ranjan Shetty, Sameer Dani, N. Prathapkumar: Sirolimus Coated Balloon in
the Treatment of Acute Coronary Syndrome: Result from the Nanolute Registry Keyur H. Parikh Page 31 of 38 Abstract Accepted:
TCT 388 Journal of The American College of cardiology Vol 68. No 18 Suppl 8, 2016
23. Milan Chag, Parloop Bhatt, Urmil Shah, HemangBaxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Aditi Nanavati,
Piyush Thakar, Keyur Parikh. Hospital to Home Visit, an Effective Health Care Initiative to Reduce Complications and
Improve Drug Compliance and Adherence: NCDR® Participation Advantage. Accepted in NCDR 2016.
24. Urmil Shah, Milan Chag, Dhiren Shah, Ajay Naik, Hemang Baxi, Anish Chandarana, Satya Gupta, Vineet
Sankhla, Keyur Parikh, Parloop Bhatt. NCDR® as a Resource to Develop Cardiac Disease Specific Clinical Care Clinics.
Accepted in NCDR 2016.
Publication List (Last 6 Years)
100
25. Urmil Shah, Milan Chag, HemangBaxi, Anish Chandarana, Satya Gupta, Vineet Sankhla, Keyur Parikh, Parloop Bhatt.
An Asian Indian Single Center Radial Access Percutaneous Coronary Intervention Experience: NCDR® Findings.
Accepted in NCDR 2016.
26. Satya Gupta, Parloop Bhatt, Milan Chag, Parth Parikh, ,Roosha Parikh, Apurva Patel, Aditi Nanavati, Piyush Thakar,
Jawahar Mehta, Keyur Parikh. Depression Adversely Affects Long Term Outcomes in Acute Coronary Syndrome Patients: A Real
World Scenario. Accepted in SCAI 2016.
27. Satya Gupta, Parloop Bhatt, Milan Chag, Parth Parikh, Aditi Patel, Vatsal Chhaya, Anish Chandarana, HemangBaxi,
Urmil Shah, Dhiren Shah, Ajay Naik, Keyur Parikh. Temporal Trends in Young Indian Heart Failure Patients: A Ray of
Hope. Accepted in SCAI 2016.
28. Satya Gupta, Parloop Bhatt, Milan Chag, Parth Parikh, Aditi Patel, Roosha Parikh, Apurva Patel, Apurva Patel, Aditi
Nanavati, Anish Chandarana, HemangBaxi, Effect of Mono-therapy versus Combinational Therapy on Exercise Capacity of
Pulmonary Arterial Hypertension Patients: Actual Care Data. Accepted in SCAI 2016.
29. Satya Gupta, Parloop Bhatt, Milan Chag, Nairuti Trivedi, Keyur Parikh, Apurva Patel, Roosha Parikh, Parth Parikh, Aditi Patel,
Jawahar Mehta, Dhiren Shah. Chest Pain in Acute Coronary Syndrome Patients with Depression after 179 Bypass Surgeries.
Accepted in SCAI 2016.
30. Keyur Parikh, Ranjan Shetty, Sameer Dani, Parloop Bhatt, Manish Doshi, Prakash Sojitra. Real-world Safety and Outcome
Measures of Novel Sirolimus Coated Balloon Catheter. Accepted in ACC 2016.
31. Keyur H. Parikh, Satya Gupta, Parth Parikh, Aditi Patel, Aporva Patel, Roosha Parikh, Anish Chandarana, Milan Chag,
HemangBaxi, Urmil Shah, Sustained Long Term Safety Out comes of “NEOVASC” Coronary Sinus Reducer in No Option
Patients of Refractory Angina: 10 Year Follow up. Accepted in SCAI 2016.
32. Parloop Bhatt, Parth Parikh, Aditi Patel, Roosha Parikh, Apurva Patel, Jawahar L. Mehta, Keyur Parikh: Unique Aspects of
Coronary Artery Disease in Indian Women Abstract Accepted; Cardiovascular Drug & Therapy, 26th May 2015, by Springer.
33. Parloop Bhatt, Parth Parikh, Apurva Patel, Milan Chag, Anish Chandarana, Roosha Parikh, Keyur Parikh: Long-term
Safety and Performance of the Orbital Atherectomy System for Treating Calcified Coronary Artery Lesions: 5-Year Follow-
Up in the ORBIT I Trial Cardiovascular Revascularization Medicine. (Accepted as a publication Cardiovascular
Revascularization Medicine 2016, S1553-8389 (15) 00091-3
Publication List (Last 6 Years)
101
34. Parth Parikh, Aditi Patel, Apurva Patel, Roosha Parikh, Keyur Parikh. Novel First in man use of first ever Sirolimus Drug Coated
Balloon in carotid in stent restenosis. (Accepted as a Poster Presentation in American College of Cardiology ACC March -
2015)
35. Parloop Bhatt, Aditi Patel, Parth Parikh, Jawahar Mehta, Piyush Thakar, Aditi Nanavati, Roosha Parikh, Apurva Patel, Keyur
Parikh. Depression and Outcome of Patients with Acute Coronary Syndrome: A 3 Year Follow-up Study. (Accepted as a Poster
Presentation in American College of Cardiology ACC March -2015)
36. Apurva Patel, Roosha Parikh, Parth Parikh, Milan Chag, Urmil Shah, HemangBaxi, Anish Chandarana, Satya Gupta,
Vineet Sankhla, Chintan Mehta, Neil Mehta, Jawahar Mehta, Parloop Bhatt, Keyur Parikh: A Hospital to Home Visit
Model to Ensure Medical Compliance and Reduce Complications Following Percutaneous Coronary
Intervention: A Novel Global Concept. Accepted as a presented at the Society for
cardiovascular Angiography and Intervention(SCAI) May 28-31,2014 Las Vegas, USA.
37. Niren Bhavsar, Roosha Parikh, Apurva Patel, Parth Parikh, Satya Gupta, Dhaval Naik, Chintan Mehta, Parloop
Bhatt, Keyur Parikh, Dhiren Shah: Comparative Safety and Efficacy Evaluation of Ivabradine, Metoprolol and its
Combination in Management of Inappropriate Sinus Tachycardia in Coronary Artery Bypass Graft patients. (Submitted
in American College of Cardiology ACC March -2014) Volume 63, Issue 12, A1569 doi: 10.1016/S0735-
1097(14)61572-2 Jam Col lCardiol . 2014; 63(12_S):.doi:10.1016/S0735-1097(14)61572-2
38. Roosha Parikh, Apurva Patel, Shmuel Banai, Parth Parikh, Milan Chag, Urmil Shah, HemangBaxi, Anish Chandarana,
Ajay Naik, Satya Gupta, Vineet Sankhla, Parloop Bhatt, Keyur Parikh: A Possible Alternative Percutaneous Treatment
for Patients with Disabling No-Option Angina: “Neovasc” Coronary Sinus Reducer Assessment - 8 Year Follow Up.
Presented at SCAI, May 28-31,2014 Las Vegas, USA.
39. Apurva Patel, Roosha Parikh, Parth Parikh, Milan Chag, Urmil Shah, HemangBaxi, Anish Chandarana, Satya Gupta,
Vineet Sankhla, Parloop Bhatt, Keyur Parikh: Orbital Atherectomy System in Treating Calcified Coronary
Lesions: First in Man Assessment- 5 Year Follow Up. Presented at SCAI, May 28-31, 2014 Las Vegas, USA.
40. Apurva Patel, Roosha Parikh, Anish Chandarana, Parloop Bhatt, Milan Chag, Satya Gupta, HemangBaxi, Vineet
Sankhla, Mehul Dudhasia, Urmil Shah, Keyur Parikh: Short-term Outcomes In Coronary Artery Disease
Patients With Multi-Lesion Disease Implanted With Multiple Bio absorbable Vascular Scaffolds. Submitted in American
College of Cardiology ACC, March 29-31,2014 Washington DC, USA.
41. Roosha Parikh, Apurva Patel, Parth Parikh, Keyur Parikh, Dhaval Naik, Niren Bhavsar, Hiren Dholakia, Chintan
Mehta, Neil Mehta, Parloop Bhatt, Jawahar Mehta, Dhiren Shah: A Hospital to Home Health Care Initiative for Early Follow-
up, Post Discharge Management, Patient Self Care and Activation Following Coronary Artery Bypass Graft Surgery -
A First Indian Pilot Study Submitted in American College of Cardiology ACC, March 29-31,2014 Washington DC,
USA.
Publication List (Last 6 Years)
102
42. Roosha Parikh, Apurva Patel, Parth Parikh, Milan Chag, Urmil Shah, HemangBaxi, Anish Chandarana, Satya Gupta,
Piyush Thakar, Jawahar Mehta, Parloop Bhatt, Vineet Sankhla, Keyur Parikh: Increasing Penetration of Drug Eluting
Stents in Developing Countries - A Single Center 10 year Study Submitted in American College of Cardiology ACC, March
29-31,2014 Washington DC, USA.
43. Parloop Bhatt, Apurva Patel, Roosha Parikh, Parth Parikh, Aditi Patel, Satya Gupta, Jawahar Mehta,
WafiaEteiba, Sharon Mulvagh, Giuseppe Ambrosio, Naranjan Dhalla, James Willerson, Keyur Parikh:
International Task Force for Prevention of Cardiovascular Disease: Determining Factors to Assess Primary
Prevention Outcomes in Western India Submitted in American College of Cardiology ACC, March 29-31,2014
Washington DC, USA.
44. Parloop Bhatt, Parth Parikh, Apurva Patel, Milan Chag, Anish Chandarana, Roosha Parikh, Keyur Parikh: Orbital Atherectomy
System in Treating Calcified Coronary Lesions: 3-Year Follow-Up in First Human Use Study (ORBIT I Trial).
Accepted as a publication Cardiovascular revascularization medicine: including molecular interventions 06/2014;
15(4). DOI: 10.1016/j.carrev.2014.03.004
45. William Wijns, Ph. Gabriel Steg, Laura Mauri, Volkhard Kurowski, Keyur Parikh, Runlin Gao, Christoph Bode, John P.
Greenwood, Erik Lipsic, FarqadAlamgir, Tessa Rademaker-Havinga, Eric Boersma, Peter Radke, Frank van Leeuwen,
and EdoardoCamenzind for the PROTECT Steering Committee and Investigators- Endeavour zotarolimus-eluting
stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4
year results of the PROTECT randomized trial. Accepted and Published in European Heart Journal Advance
Access published 08/2014; 35(40). DOI:10.1093/eurheartj/ehu318 14.72 Impact Factor
46. Parloop A. Bhatt ,Advances in heart health-The need for developing Indian guidelines for cardiovascular disease in
women, CV Network-The official bulletin of the international academy of cardiovascular sciences, Vol. 13 No. 4 -
November 2014. International 22 CV Network – Vol. 13 No. 4 – November 2014
47. Bhatt PA, Parikh PK and Parikh KH. Prevalence, Assessment and Clinical Outcome in Cardiovascular
Disease: Impact of Gender Disparities. Austin J PharmacolTher. 2014; 2 (8).4. Peer Reviewed.
International. Austin J PharmacolTher - Volume 2 Issue 8 - 2014
48. Parloop A. Bhatt, Akhita B. Bhatt, Coenzyme Q10 supplement in breast cancer: The nutrient on horizon,
Kadakia International Journal of Research in Multidiscipline, ISSN: 2349 – 4875, Volume 1, Issue 1, June 2014,
150-158. Peer Reviewed. National. Volume 1, Issue 1, June 2014
Publication List (Last 6 Years)
Ambulance : +91-98244 50000 | 97234 50000 | 24 X 7 Medical Helpline +91 70 69 00 00 00Emergency :
CIMS Hospital
Regd Office: Plot No.67/1, Opp. Panchamrut Bunglows,
Nr. Shukan Mall, Off Science City Road, Sola, Ahmedabad - 380060.
Ph. : +91-79-4805 2771-72 Fax: +91-79-4805 2770
For appointment call : +91-79-4805 1008
Mobile : +91-98250 66661 or email on [email protected]
CIMS Hospital Pvt. Ltd. | CIN : U85110GJ2001PTC039962 | [email protected] | www.cims.org